<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Atorvastatin - Wikipedia, the free encyclopedia</title>
<script>document.documentElement.className = document.documentElement.className.replace( /(^|\s)client-nojs(\s|$)/, "$1client-js$2" );</script>
<script>window.RLQ = window.RLQ || []; window.RLQ.push( function () {
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Atorvastatin","wgTitle":"Atorvastatin","wgCurRevisionId":701883901,"wgRevisionId":701883901,"wgArticleId":634622,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Pages using citations with accessdate and no URL","Articles with changed DrugBank identifier","Articles with changed FDA identifier","Chemical articles having calculated molecular weight overwritten","Drugboxes which contain changes to verified fields","Drugboxes which contain changes to watched fields","Use dmy dates from January 2011","Anilides","Diols","Fluoroarenes","Pfizer products","Pyrroles","Statins"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Atorvastatin","wgRelevantArticleId":634622,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wikilove-recipient":"","wikilove-anon":0,"wgGatherShouldShowTutorial":true,"wgGatherEnableSample":0,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/1/1e/Atorvastatin2DCSD.svg/100px-Atorvastatin2DCSD.svg.png","wgRelatedArticles":null,"wgRelatedArticlesUseCirrusSearch":true,"wgRelatedArticlesOnlyUseCirrusSearch":false,"wgULSAcceptLanguageList":["en-us","en"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgCentralNoticeCategoriesUsingLegacy":["Fundraising","fundraising"],"wgCentralAuthMobileDomain":false,"wgWikibaseItemId":"Q668093","wgVisualEditorToolbarScrollOffset":0}); /* @nomin */mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});mw.loader.implement("user.tokens",function ( $, jQuery ) {
mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"}); /* @nomin */ ;

});mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","ext.centralauth.centralautologin","ext.gadget.WatchlistBase","ext.gadget.WatchlistGreenIndicators","mmv.head","ext.visualEditor.desktopArticleTarget.init","ext.uls.init","ext.uls.interface","ext.quicksurveys.init","mw.MediaWikiPlayer.loader","mw.PopUpMediaTransform","ext.centralNotice.bannerController","skins.vector.js"]);
} );</script>
<link rel="stylesheet" href="/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistBase%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.tmh.thumbnail.styles%7Cext.uls.nojs%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.raggett%2CsectionAnchor%7Cmediawiki.skinning.interface%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector" />
<script async="" src="/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector"></script>
<meta name="generator" content="MediaWiki 1.27.0-wmf.10" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Atorvastatin" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Atorvastatin&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Atorvastatin&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Atorvastatin" />
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.27.0-wmf.10/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Atorvastatin skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Atorvastatin</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em;border-spacing:2px;">
<caption>Atorvastatin (<a href="/wiki/International_Nonproprietary_Name" title="International Nonproprietary Name" class="mw-redirect">INN</a>)</caption>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Atorvastatin2DCSD.svg" class="image"><img alt="Atorvastatin2DCSD.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/1e/Atorvastatin2DCSD.svg/300px-Atorvastatin2DCSD.svg.png" width="300" height="154" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/1e/Atorvastatin2DCSD.svg/450px-Atorvastatin2DCSD.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1e/Atorvastatin2DCSD.svg/600px-Atorvastatin2DCSD.svg.png 2x" data-file-width="1580" data-file-height="812" /></a></td>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Atorvastatin-3D-balls.png" class="image"><img alt="Atorvastatin-3D-balls.png" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/98/Atorvastatin-3D-balls.png/250px-Atorvastatin-3D-balls.png" width="250" height="167" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/98/Atorvastatin-3D-balls.png/375px-Atorvastatin-3D-balls.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/98/Atorvastatin-3D-balls.png/500px-Atorvastatin-3D-balls.png 2x" data-file-width="1100" data-file-height="735" /></a></td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd">Systematic (<a href="/wiki/International_Union_of_Pure_and_Applied_Chemistry_nomenclature" title="International Union of Pure and Applied Chemistry nomenclature" class="mw-redirect">IUPAC</a>) name</th>
</tr>
<tr>
<td colspan="2" style="text-align:center">
<div style="word-wrap:break-word; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size:11px; line-height:120%">(3<i>R</i>,5<i>R</i>)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd">Clinical data</th>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;">Pronunciation</th>
<td><span class="nowrap"><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English" title="Help:IPA for English">/<span style="border-bottom:1px dotted"><span title="/ə/ 'a' in 'about'">ə</span><span title="/ˌ/ secondary stress follows">ˌ</span><span title="'t' in 'tie'">t</span><span title="/ɔːr/ 'or' in 'born'">ɔːr</span><span title="'v' in 'vie'">v</span><span title="/ə/ 'a' in 'about'">ə</span><span title="/ˈ/ primary stress follows">ˈ</span><span title="'s' in 'sigh'">s</span><span title="'t' in 'tie'">t</span><span title="/æ/ short 'a' in 'bad'">æ</span><span title="'t' in 'tie'">t</span><span title="/ən/ 'on' in 'button'">ən</span></span>/</a></span></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Drug_nomenclature#Trade_names" title="Drug nomenclature">Trade names</a></th>
<td>Lipitor, Atorva</td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/American_Society_of_Health-System_Pharmacists" title="American Society of Health-System Pharmacists">AHFS</a>/<a href="/wiki/Drugs.com" title="Drugs.com">Drugs.com</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.drugs.com/monograph/lipitor.html">monograph</a></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/druginfo/meds/a600045.html">a600045</a></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Licence data</a></th>
<td><a href="/wiki/Daily_Med" title="Daily Med" class="mw-redirect">US&#160;Daily&#160;Med</a>:<span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=42465">link</a></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Pregnancy_category" title="Pregnancy category">Pregnancy<br />
category</a></th>
<td>
<div class="plainlist">
<ul>
<li><small><abbr title="Australia">AU</abbr>:</small> <a href="/wiki/Pregnancy_category#Australia" title="Pregnancy category">D</a></li>
<li><small><abbr title="United States">US</abbr>:</small> <a href="/wiki/Pregnancy_category#United_States" title="Pregnancy category">X</a> (Contraindicated)</li>
</ul>
<ul>
<li class="mw-empty-li"></li>
</ul>
</div>
</td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a></th>
<td>
<div class="plainlist">
<ul>
<li><small><abbr title="Australia">AU</abbr>:</small> <a href="/wiki/Standard_for_the_Uniform_Scheduling_of_Drugs_and_Poisons#Schedule_4_Prescription_Only_Medicine" title="Standard for the Uniform Scheduling of Drugs and Poisons" class="mw-redirect">S4</a> (Prescription only)</li>
<li><small><abbr title="United Kingdom">UK</abbr>:</small> <a href="/wiki/Prescription_drug" title="Prescription drug">POM</a> (Prescription only)</li>
<li><small><abbr title="United States">US</abbr>:</small> <a href="/wiki/Prescription_drug" title="Prescription drug"><span class="Unicode">℞</span>-only</a></li>
</ul>
</div>
</td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Route_of_administration" title="Route of administration">Routes of<br />
administration</a></th>
<td>Oral</td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd"><a href="/wiki/Pharmacokinetics" title="Pharmacokinetics">Pharmacokinetic</a> data</th>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Bioavailability" title="Bioavailability">Bioavailability</a></th>
<td>12%</td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Drug_metabolism" title="Drug metabolism">Metabolism</a></th>
<td><a href="/wiki/Liver" title="Liver">Hepatic</a> - <a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Biological_half-life" title="Biological half-life">Biological half-life</a></th>
<td>14 h</td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Excretion" title="Excretion">Excretion</a></th>
<td><a href="/wiki/Bile" title="Bile">Bile</a></td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd">Identifiers</th>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/CAS_Registry_Number" title="CAS Registry Number">CAS Number</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=134523-00-5">134523-00-5</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></th>
<td><a href="/wiki/ATC_code_C10" title="ATC code C10">C10</a><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.whocc.no/atc_ddd_index/?code=C10AA05">AA05</a></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/PubChem" title="PubChem">PubChem</a></th>
<td>CID <span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="//pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=60823">60823</a></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/IUPHAR/BPS" title="IUPHAR/BPS" class="mw-redirect">IUPHAR/BPS</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2949">2949</a></span></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/DrugBank" title="DrugBank">DrugBank</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.drugbank.ca/drugs/APRD00055">APRD00055</a></span><sup>&#160;<img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png" width="7" height="8" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/11px-X_mark.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png 2x" data-file-width="525" data-file-height="600" /><span style="display:none">N</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/ChemSpider" title="ChemSpider">ChemSpider</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.chemspider.com/Chemical-Structure.54810.html">54810</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Unique_Ingredient_Identifier" title="Unique Ingredient Identifier">UNII</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=A0JWA85V8F">A0JWA85V8F</a></span><sup>&#160;<img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png" width="7" height="8" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/11px-X_mark.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png 2x" data-file-width="525" data-file-height="600" /><span style="display:none">N</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/KEGG" title="KEGG">KEGG</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.kegg.jp/entry/D07474">D07474</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/ChEBI" title="ChEBI">ChEBI</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:39548">CHEBI:39548</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/ChEMBL" title="ChEMBL">ChEMBL</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1487">CHEMBL1487</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Protein_Data_Bank" title="Protein Data Bank">PDB</a> ligand ID</th>
<td>117 (<span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=117">PDBe</a></span>, <span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&amp;chemCompId=117&amp;polymericType=Any">RCSB PDB</a></span>)</td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd">Chemical data</th>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Chemical_formula" title="Chemical formula">Formula</a></th>
<td><span title="Carbon">C</span><sub>33</sub><span title="Hydrogen">H</span><sub>35</sub><span title="Fluorine">F</span><span title="Nitrogen">N</span><sub>2</sub><span title="Oxygen">O</span><sub>5</sub></td>
</tr>
<tr>
<th scope="row" style="padding:0.1em 0; line-height:1.2em;"><a href="/wiki/Molar_mass" title="Molar mass">Molar mass</a></th>
<td>558.64</td>
</tr>
<tr>
<td colspan="2" style="text-align:center">
<div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;"><a href="/wiki/Simplified_molecular_input_line_entry_specification" title="Simplified molecular input line entry specification" class="mw-redirect">SMILES</a></div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;">
<li style="line-height: inherit; margin: 0">
<div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(O)C[C@H](O)C[C@H](O)CCn2c(c(c(c2c1ccc(F)cc1)c3ccccc3)C(=O)Nc4ccccc4)C(C)C</div>
</li>
</ul>
</div>
</td>
</tr>
<tr>
<td colspan="2" style="text-align:center">
<div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;"><a href="/wiki/International_Chemical_Identifier" title="International Chemical Identifier">InChI</a></div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;">
<li style="line-height: inherit; margin: 0">
<div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1<sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></div>
</li>
<li style="line-height: inherit; margin: 0">
<div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:XUKUURHRXDUEBC-KAYWLYCHSA-N<sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup></div>
</li>
</ul>
</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center;background:#ddd"><span style="font-weight:normal;">&#160;<sup><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png" width="7" height="8" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/11px-X_mark.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png 2x" data-file-width="525" data-file-height="600" /><span style="display:none">N</span><img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" data-file-width="600" data-file-height="600" /><span style="display:none">Y</span></sup>&#160;<a href="/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation" title="Wikipedia:WikiProject Chemicals/Chembox validation">(what is this?)</a></span><span style="font-weight:normal;">&#160;&#160;<span class="reflink plainlinks nourlexpansion"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Special:ComparePages&amp;rev1=477861573&amp;page2=Atorvastatin">(verify)</a></span></span></th>
</tr>
</table>
<p><b>Atorvastatin</b>, marketed under the trade name <b>Lipitor</b> among others,<sup id="cite_ref-LiptHome_1-0" class="reference"><a href="#cite_note-LiptHome-1"><span>[</span>1<span>]</span></a></sup> is a member of the drug class known as <a href="/wiki/Statin" title="Statin">statins</a>, which are used primarily for lowering blood <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a> and for prevention of events associated with <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a>. Like all statins, atorvastatin works by inhibiting <a href="/wiki/HMG-CoA_reductase" title="HMG-CoA reductase">HMG-CoA reductase</a>, an <a href="/wiki/Enzyme" title="Enzyme">enzyme</a> found in <a href="/wiki/Liver" title="Liver">liver</a> tissue that plays a key role in production of cholesterol in the body.</p>
<p>The synthesis of atorvastatin took place in August 1985 at <a href="/wiki/Warner-Lambert" title="Warner-Lambert" class="mw-redirect">Warner-Lambert</a>'s <a href="/wiki/Parke-Davis" title="Parke-Davis">Parke-Davis</a> Pharmaceutical Research facility in <a href="/wiki/Ann_Arbor,_Michigan" title="Ann Arbor, Michigan">Ann Arbor, Michigan</a>.<sup id="cite_ref-WSJ_blockbuster_2000_2-0" class="reference"><a href="#cite_note-WSJ_blockbuster_2000-2"><span>[</span>2<span>]</span></a></sup> by <a href="/wiki/Bruce_Roth" title="Bruce Roth">Bruce Roth</a>, leading a team of 18 scientists researching <a href="/wiki/Atherosclerosis" title="Atherosclerosis">atherosclerosis</a>.<sup id="cite_ref-Roth_2002_3-0" class="reference"><a href="#cite_note-Roth_2002-3"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-Roth_2002_3-1" class="reference"><a href="#cite_note-Roth_2002-3"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-Fortune_2003_4-0" class="reference"><a href="#cite_note-Fortune_2003-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-Fortune_2003_4-1" class="reference"><a href="#cite_note-Fortune_2003-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-US4681893_5-0" class="reference"><a href="#cite_note-US4681893-5"><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-History_Parke-Davis_6-0" class="reference"><a href="#cite_note-History_Parke-Davis-6"><span>[</span>6<span>]</span></a></sup><sup id="cite_ref-NYT_2000_7-0" class="reference"><a href="#cite_note-NYT_2000-7"><span>[</span>7<span>]</span></a></sup> From 1996 to 2012 under the trade name Lipitor, atorvastatin became the world's best-selling drug of all time, with more than <a href="/wiki/US$" title="US$" class="mw-redirect">US$</a>125 billion in sales over approximately 14.5 years.<sup id="cite_ref-Crain_2011_8-0" class="reference"><a href="#cite_note-Crain_2011-8"><span>[</span>8<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Medical_uses"><span class="tocnumber">1</span> <span class="toctext">Medical uses</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Dyslipidemia"><span class="tocnumber">1.1</span> <span class="toctext">Dyslipidemia</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Cardiovascular_disease"><span class="tocnumber">1.2</span> <span class="toctext">Cardiovascular disease</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Other_uses"><span class="tocnumber">1.3</span> <span class="toctext">Other uses</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-5"><a href="#Administration"><span class="tocnumber">2</span> <span class="toctext">Administration</span></a>
<ul>
<li class="toclevel-2 tocsection-6"><a href="#Specific_populations"><span class="tocnumber">2.1</span> <span class="toctext">Specific populations</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-7"><a href="#Contraindications"><span class="tocnumber">3</span> <span class="toctext">Contraindications</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#Adverse_effects"><span class="tocnumber">4</span> <span class="toctext">Adverse effects</span></a>
<ul>
<li class="toclevel-2 tocsection-9"><a href="#Major"><span class="tocnumber">4.1</span> <span class="toctext">Major</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Common"><span class="tocnumber">4.2</span> <span class="toctext">Common</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Other"><span class="tocnumber">4.3</span> <span class="toctext">Other</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#Interactions"><span class="tocnumber">4.4</span> <span class="toctext">Interactions</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-13"><a href="#Mechanism_of_action"><span class="tocnumber">5</span> <span class="toctext">Mechanism of action</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#Pharmacodynamics"><span class="tocnumber">6</span> <span class="toctext">Pharmacodynamics</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#Pharmacokinetics"><span class="tocnumber">7</span> <span class="toctext">Pharmacokinetics</span></a>
<ul>
<li class="toclevel-2 tocsection-16"><a href="#Absorption"><span class="tocnumber">7.1</span> <span class="toctext">Absorption</span></a></li>
<li class="toclevel-2 tocsection-17"><a href="#Distribution"><span class="tocnumber">7.2</span> <span class="toctext">Distribution</span></a></li>
<li class="toclevel-2 tocsection-18"><a href="#Metabolism"><span class="tocnumber">7.3</span> <span class="toctext">Metabolism</span></a></li>
<li class="toclevel-2 tocsection-19"><a href="#Excretion"><span class="tocnumber">7.4</span> <span class="toctext">Excretion</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-20"><a href="#Pharmacogenetics"><span class="tocnumber">8</span> <span class="toctext">Pharmacogenetics</span></a></li>
<li class="toclevel-1 tocsection-21"><a href="#Chemical_synthesis"><span class="tocnumber">9</span> <span class="toctext">Chemical synthesis</span></a></li>
<li class="toclevel-1 tocsection-22"><a href="#History"><span class="tocnumber">10</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-23"><a href="#Formulations"><span class="tocnumber">11</span> <span class="toctext">Formulations</span></a></li>
<li class="toclevel-1 tocsection-24"><a href="#Generic_availability"><span class="tocnumber">12</span> <span class="toctext">Generic availability</span></a></li>
<li class="toclevel-1 tocsection-25"><a href="#Drug_recall"><span class="tocnumber">13</span> <span class="toctext">Drug recall</span></a></li>
<li class="toclevel-1 tocsection-26"><a href="#References"><span class="tocnumber">14</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-27"><a href="#Further_reading"><span class="tocnumber">15</span> <span class="toctext">Further reading</span></a></li>
<li class="toclevel-1 tocsection-28"><a href="#External_links"><span class="tocnumber">16</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Medical_uses">Medical uses</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=1" title="Edit section: Medical uses">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The primary uses of atorvastatin is for the treatment of <a href="/wiki/Dyslipidemia" title="Dyslipidemia">dyslipidemia</a> and the prevention of <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a>:<sup id="cite_ref-AHFS_9-0" class="reference"><a href="#cite_note-AHFS-9"><span>[</span>9<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Dyslipidemia">Dyslipidemia</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=2" title="Edit section: Dyslipidemia">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<ul>
<li><a href="/wiki/Hypercholesterolemia" title="Hypercholesterolemia">Hypercholesterolemia</a><sup id="cite_ref-pmid12915827_10-0" class="reference"><a href="#cite_note-pmid12915827-10"><span>[</span>10<span>]</span></a></sup> (<a href="/wiki/Familial_hypercholesterolemia#Heterozygous_FH" title="Familial hypercholesterolemia">heterozygous familial and nonfamilial</a>) and mixed <a href="/wiki/Dyslipidemia" title="Dyslipidemia">dyslipidemia</a> (<a href="/wiki/Fredrickson_classification#Type_IIa" title="Fredrickson classification" class="mw-redirect">Fredrickson types IIa</a> and <a href="/wiki/Fredrickson_classification#Type_IIb" title="Fredrickson classification" class="mw-redirect">IIb</a>) to reduce total <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a>, <a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">LDL-C</a>,<sup id="cite_ref-Nissen_2006_11-0" class="reference"><a href="#cite_note-Nissen_2006-11"><span>[</span>11<span>]</span></a></sup> <a href="/wiki/Apolipoprotein_B" title="Apolipoprotein B">apo-B</a>,<sup id="cite_ref-pmid7749881_12-0" class="reference"><a href="#cite_note-pmid7749881-12"><span>[</span>12<span>]</span></a></sup> <a href="/wiki/Triglyceride" title="Triglyceride">triglycerides</a><sup id="cite_ref-pmid8531308_13-0" class="reference"><a href="#cite_note-pmid8531308-13"><span>[</span>13<span>]</span></a></sup> levels, and <a href="/wiki/C-reactive_protein" title="C-reactive protein">CRP</a><sup id="cite_ref-pmid16908955_14-0" class="reference"><a href="#cite_note-pmid16908955-14"><span>[</span>14<span>]</span></a></sup> as well as increase <a href="/wiki/High_density_lipoprotein" title="High density lipoprotein" class="mw-redirect">HDL</a> levels.</li>
<li><a href="/wiki/Familial_hypercholesterolemia#Heterozygous_FH" title="Familial hypercholesterolemia">Heterozygous familial hypercholesterolemia</a><sup id="cite_ref-pmid12915827_10-1" class="reference"><a href="#cite_note-pmid12915827-10"><span>[</span>10<span>]</span></a></sup> in <a href="/wiki/Pediatrics" title="Pediatrics">pediatric</a> patients</li>
<li><a href="/wiki/Familial_hypercholesterolemia#Homozygous_FH" title="Familial hypercholesterolemia">Homozygous familial hypercholesterolemia</a><sup id="cite_ref-pmid12915827_10-2" class="reference"><a href="#cite_note-pmid12915827-10"><span>[</span>10<span>]</span></a></sup><sup id="cite_ref-pmid9301631_15-0" class="reference"><a href="#cite_note-pmid9301631-15"><span>[</span>15<span>]</span></a></sup></li>
<li>Hypertriglyceridemia (<a href="/wiki/Fredrickson_classification#Hyperlipoproteinemia_type_IV" title="Fredrickson classification" class="mw-redirect">Fredrickson Type IV</a>)</li>
<li>Primary dysbetalipoproteinemia (<a href="/wiki/Fredrickson_classification#Hyperlipoproteinemia_type_III" title="Fredrickson classification" class="mw-redirect">Fredrickson Type III</a>)</li>
<li><a href="/wiki/Combined_hyperlipidemia" title="Combined hyperlipidemia">Combined hyperlipidemia</a><sup id="cite_ref-AMH_2006_16-0" class="reference"><a href="#cite_note-AMH_2006-16"><span>[</span>16<span>]</span></a></sup></li>
</ul>
<h3><span class="mw-headline" id="Cardiovascular_disease">Cardiovascular disease</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=3" title="Edit section: Cardiovascular disease">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<ul>
<li><a href="/wiki/Primary_prevention" title="Primary prevention" class="mw-redirect">Primary prevention</a> of heart attack, stroke, and need for revascularization procedures in patients who have risk factors such as age, smoking, high blood pressure, low HDL-C, and a family history of early heart disease, but have not yet developed clinically evident <a href="/wiki/Coronary_disease" title="Coronary disease" class="mw-redirect">coronary heart disease</a>.<sup id="cite_ref-url__atorvastatin_labeling.pfizer.com_17-0" class="reference"><a href="#cite_note-url_atorvastatin_labeling.pfizer.com-17"><span>[</span>17<span>]</span></a></sup></li>
<li><a href="/wiki/Secondary_prevention" title="Secondary prevention" class="mw-redirect">Secondary prevention</a> of <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a>, <a href="/wiki/Stroke" title="Stroke">stroke</a>, <a href="/wiki/Unstable_angina" title="Unstable angina">unstable angina</a>,<sup id="cite_ref-pmid12686036_18-0" class="reference"><a href="#cite_note-pmid12686036-18"><span>[</span>18<span>]</span></a></sup><sup id="cite_ref-pmid12829554_19-0" class="reference"><a href="#cite_note-pmid12829554-19"><span>[</span>19<span>]</span></a></sup> and <a href="/wiki/Revascularization" title="Revascularization">revascularization</a> in people with established <a href="/wiki/Coronary_disease" title="Coronary disease" class="mw-redirect">coronary heart disease</a>.<sup id="cite_ref-Wilson_2008_20-0" class="reference"><a href="#cite_note-Wilson_2008-20"><span>[</span>20<span>]</span></a></sup><sup id="cite_ref-pmid9514454_21-0" class="reference"><a href="#cite_note-pmid9514454-21"><span>[</span>21<span>]</span></a></sup></li>
<li>Myocardial infarction and stroke prophylaxis in patients with <a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">type II diabetes</a><sup id="cite_ref-pmid15325833_22-0" class="reference"><a href="#cite_note-pmid15325833-22"><span>[</span>22<span>]</span></a></sup><sup id="cite_ref-pmid17065671_23-0" class="reference"><a href="#cite_note-pmid17065671-23"><span>[</span>23<span>]</span></a></sup><sup id="cite_ref-pmid11225965_24-0" class="reference"><a href="#cite_note-pmid11225965-24"><span>[</span>24<span>]</span></a></sup></li>
</ul>
<h3><span class="mw-headline" id="Other_uses">Other uses</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=4" title="Edit section: Other uses">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>There have been recent studies suggesting that high-dose <a href="/wiki/Statin" title="Statin">statin</a> therapy plays a plaque-stabilizing role in patients suffering from <a href="/wiki/Acute_coronary_syndrome" title="Acute coronary syndrome">acute coronary syndrome</a> and <a href="/wiki/Thrombotic_stroke" title="Thrombotic stroke" class="mw-redirect">thrombotic stroke</a>.<sup id="cite_ref-Rosa_501.E2.80.9315_25-0" class="reference"><a href="#cite_note-Rosa_501.E2.80.9315-25"><span>[</span>25<span>]</span></a></sup><sup id="cite_ref-Furie_1994.E2.80.935_26-0" class="reference"><a href="#cite_note-Furie_1994.E2.80.935-26"><span>[</span>26<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Administration">Administration</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=5" title="Edit section: Administration">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Atorvastatin may be used in combination with <a href="/wiki/Bile_acid_sequestrants" title="Bile acid sequestrants" class="mw-redirect">bile acid sequestrants</a> and <a href="/wiki/Ezetimibe" title="Ezetimibe">ezetimibe</a> to increase the reduction in cholesterol levels. However, It is not recommended to combine statin drug treatment with certain other cholesterol-lowering drugs, particularly <a href="/wiki/Fibrates" title="Fibrates" class="mw-redirect">fibrates</a>, because this may increase the risk of myopathy-related adverse effects.<sup id="cite_ref-url__atorvastatin_labeling.pfizer.com_17-1" class="reference"><a href="#cite_note-url_atorvastatin_labeling.pfizer.com-17"><span>[</span>17<span>]</span></a></sup></p>
<p>While many statin medications should be administered at bedtime for optimal effect, atorvastatin can be dosed at any time of day, as long as it is continually dosed once daily at the same time.<sup id="cite_ref-pmid11368702_27-0" class="reference"><a href="#cite_note-pmid11368702-27"><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-pmid15249516_28-0" class="reference"><a href="#cite_note-pmid15249516-28"><span>[</span>28<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Specific_populations">Specific populations</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=6" title="Edit section: Specific populations">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<ul>
<li><b>Geriatric</b>: Plasma concentrations of atorvastatin in healthy elderly subjects are higher than those in young adults, and clinical data suggests a greater degree of LDL-lowering at any dose for patients in the population as compared to young adults.<sup id="cite_ref-url__atorvastatin_labeling.pfizer.com_17-2" class="reference"><a href="#cite_note-url_atorvastatin_labeling.pfizer.com-17"><span>[</span>17<span>]</span></a></sup></li>
<li><b>Pediatric</b>: Pharmacokinetic data is not available for this population.<sup id="cite_ref-url__atorvastatin_labeling.pfizer.com_17-3" class="reference"><a href="#cite_note-url_atorvastatin_labeling.pfizer.com-17"><span>[</span>17<span>]</span></a></sup></li>
<li><b>Gender</b>: Plasma concentrations are generally higher in women than in men, but there is no clinically significant difference in the extent of LDL reduction between men and women.<sup id="cite_ref-url__atorvastatin_labeling.pfizer.com_17-4" class="reference"><a href="#cite_note-url_atorvastatin_labeling.pfizer.com-17"><span>[</span>17<span>]</span></a></sup></li>
<li><b>Renal impairment</b>: Renal disease has no influence on plasma concentrations of atorvastatin and dosing need not be adjusted in these patients.<sup id="cite_ref-url__atorvastatin_labeling.pfizer.com_17-5" class="reference"><a href="#cite_note-url_atorvastatin_labeling.pfizer.com-17"><span>[</span>17<span>]</span></a></sup></li>
<li><b>Hemodialysis</b>: Hemodialysis will not significantly alter drug levels or change clinical effect of atorvastatin.<sup id="cite_ref-url__atorvastatin_labeling.pfizer.com_17-6" class="reference"><a href="#cite_note-url_atorvastatin_labeling.pfizer.com-17"><span>[</span>17<span>]</span></a></sup></li>
<li><b>Hepatic impairment</b>: In patients with chronic <a href="/wiki/Alcoholic_liver_disease" title="Alcoholic liver disease">alcoholic liver disease</a>, levels of atorvastatin may be significantly increased depending upon the extent of liver disease.<sup id="cite_ref-url__atorvastatin_labeling.pfizer.com_17-7" class="reference"><a href="#cite_note-url_atorvastatin_labeling.pfizer.com-17"><span>[</span>17<span>]</span></a></sup></li>
</ul>
<h2><span class="mw-headline" id="Contraindications">Contraindications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=7" title="Edit section: Contraindications">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li>Active liver disease: <a href="/wiki/Cholestasis" title="Cholestasis">cholestasis</a>, <a href="/wiki/Hepatic_encephalopathy" title="Hepatic encephalopathy">hepatic encephalopathy</a>, <a href="/wiki/Hepatitis" title="Hepatitis">hepatitis</a>, and <a href="/wiki/Jaundice" title="Jaundice">jaundice</a></li>
<li>Unexplained elevations in <a href="/wiki/Aspartate_transaminase" title="Aspartate transaminase">AST</a> or <a href="/wiki/Alanine_transaminase" title="Alanine transaminase">ALT</a> levels</li>
<li><a href="/wiki/Pregnancy" title="Pregnancy">Pregnancy</a>: Atorvastatin may cause fetal harm by affecting serum cholesterol and triglyceride levels, which are essential for fetal development.<sup id="cite_ref-url__atorvastatin_labeling.pfizer.com_17-8" class="reference"><a href="#cite_note-url_atorvastatin_labeling.pfizer.com-17"><span>[</span>17<span>]</span></a></sup></li>
<li><a href="/wiki/Breastfeeding" title="Breastfeeding">Breastfeeding</a>: Small amounts of other statin drugs have been found to pass into breast milk, although atorvastatin has not been studied, specifically.<sup id="cite_ref-url__atorvastatin_labeling.pfizer.com_17-9" class="reference"><a href="#cite_note-url_atorvastatin_labeling.pfizer.com-17"><span>[</span>17<span>]</span></a></sup></li>
<li>Markedly elevated <a href="/wiki/Creatine_kinase" title="Creatine kinase">CPK</a> levels or if a <a href="/wiki/Myopathy" title="Myopathy">myopathy</a> is suspected or diagnosed after dosing of atorvastatin has begun. Very rarely, atorvastatin may cause <a href="/wiki/Rhabdomyolysis" title="Rhabdomyolysis">rhabdomyolysis</a>,<sup id="cite_ref-pmid16765141_29-0" class="reference"><a href="#cite_note-pmid16765141-29"><span>[</span>29<span>]</span></a></sup> and it may be very serious leading to <a href="/wiki/Acute_kidney_injury" title="Acute kidney injury">acute renal failure</a> due to <a href="/wiki/Myoglobinuria" title="Myoglobinuria">myoglobinuria</a>. If rhabdomyolysis is suspected or diagnosed, atorvastatin therapy should be discontinued immediately.<sup id="cite_ref-pmid12036392_30-0" class="reference"><a href="#cite_note-pmid12036392-30"><span>[</span>30<span>]</span></a></sup> The likelihood of developing a <a href="/wiki/Myopathy" title="Myopathy">myopathy</a> is increased by the co-administration of <a href="/wiki/Cyclosporine" title="Cyclosporine" class="mw-redirect">cyclosporine</a>, <a href="/wiki/Fibrate" title="Fibrate">fibric acid derivatives</a>, <a href="/wiki/Erythromycin" title="Erythromycin">erythromycin</a>, <a href="/wiki/Niacin" title="Niacin">niacin</a>, and <a href="/wiki/Azole" title="Azole">azole</a> <a href="/wiki/Antifungal_medication" title="Antifungal medication" class="mw-redirect">antifungals</a>.<sup id="cite_ref-uspi_lipitor.pdf_31-0" class="reference"><a href="#cite_note-uspi_lipitor.pdf-31"><span>[</span>31<span>]</span></a></sup></li>
</ul>
<h2><span class="mw-headline" id="Adverse_effects">Adverse effects</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=8" title="Edit section: Adverse effects">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Major">Major</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=9" title="Edit section: Major">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<ul>
<li><a href="/wiki/Myopathy" title="Myopathy">Myopathy</a> with elevation of creatinine kinase (CK)<sup id="cite_ref-pmid8463436_32-0" class="reference"><a href="#cite_note-pmid8463436-32"><span>[</span>32<span>]</span></a></sup> and <a href="/wiki/Rhabdomyolysis" title="Rhabdomyolysis">rhabdomyolysis</a> are the most serious side effects, occurring rarely at a rate of 2.3 to 9.1 per 10,000 person-years among patients taking atorvastatin.<sup id="cite_ref-AMH_2006_16-1" class="reference"><a href="#cite_note-AMH_2006-16"><span>[</span>16<span>]</span></a></sup><sup id="cite_ref-uspi_lipitor.pdf_31-1" class="reference"><a href="#cite_note-uspi_lipitor.pdf-31"><span>[</span>31<span>]</span></a></sup><sup id="cite_ref-33" class="reference"><a href="#cite_note-33"><span>[</span>33<span>]</span></a></sup> As mentioned previously, atorvastatin should be discontinued immediately if this occurs.</li>
<li>Persistent liver enzyme abnormalities occurred in 0.7% of patients who received atorvastatin in clinical trials. It is recommended that hepatic function be assessed with laboratory tests before beginning atorvastatin treatment and repeated as clinically indicated thereafter. If evidence of serious liver injury occurs while a patient is taking atorvastatin, it should be discontinued and not restarted until the etiology of the patient's liver dysfunction is defined. If no other cause is found, atorvastatin should be discontinued permanently.<sup id="cite_ref-url__atorvastatin_labeling.pfizer.com_17-10" class="reference"><a href="#cite_note-url_atorvastatin_labeling.pfizer.com-17"><span>[</span>17<span>]</span></a></sup></li>
<li><a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">Diabetes mellitus type 2</a>, an uncommon class effect of all statins.<sup id="cite_ref-FDA_2014_statins_34-0" class="reference"><a href="#cite_note-FDA_2014_statins-34"><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-webmd_2012_diabetes_35-0" class="reference"><a href="#cite_note-webmd_2012_diabetes-35"><span>[</span>35<span>]</span></a></sup><sup id="cite_ref-36" class="reference"><a href="#cite_note-36"><span>[</span>36<span>]</span></a></sup></li>
</ul>
<h3><span class="mw-headline" id="Common">Common</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=10" title="Edit section: Common">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The following have been shown to occur in 1–10% of patients taking atorvastatin in clinical trials.</p>
<ul>
<li><a href="/wiki/Diarrhea" title="Diarrhea">diarrhea</a>, <a href="/wiki/Dyspepsia" title="Dyspepsia" class="mw-redirect">dyspepsia</a>, <a href="/wiki/Nausea" title="Nausea">nausea</a><sup id="cite_ref-uspi_lipitor.pdf_31-2" class="reference"><a href="#cite_note-uspi_lipitor.pdf-31"><span>[</span>31<span>]</span></a></sup></li>
<li><a href="/wiki/Arthralgia" title="Arthralgia">Arthralgia</a>, <a href="/wiki/Myalgia" title="Myalgia">myalgia</a><sup id="cite_ref-uspi_lipitor.pdf_31-3" class="reference"><a href="#cite_note-uspi_lipitor.pdf-31"><span>[</span>31<span>]</span></a></sup></li>
</ul>
<p>High-dose atorvastatin have also been associated with worsening glycemic control.<sup id="cite_ref-Mayo_Clinic_Staff_37-0" class="reference"><a href="#cite_note-Mayo_Clinic_Staff-37"><span>[</span>37<span>]</span></a></sup><sup id="cite_ref-pmid20507274_38-0" class="reference"><a href="#cite_note-pmid20507274-38"><span>[</span>38<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Other">Other</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=11" title="Edit section: Other">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In 2014 the FDA reported memory loss, forgetfulness and confusion with all statin products including atorvastatin. The symptoms were not serious, rare and reversible on cessation of drug treatment.<sup id="cite_ref-FDA_2014_statins_34-1" class="reference"><a href="#cite_note-FDA_2014_statins-34"><span>[</span>34<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Interactions">Interactions</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=12" title="Edit section: Interactions">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Interactions with clofibrate, fenofibrate, gemfibrozil, which are fibrates used in accessory therapy in many forms of <a href="/wiki/Hypercholesterolemia" title="Hypercholesterolemia">hypercholesterolemia</a>, usually in combination with statins, increase the risk of <a href="/wiki/Myopathy" title="Myopathy">myopathy</a> and <a href="/wiki/Rhabdomyolysis" title="Rhabdomyolysis">rhabdomyolysis</a>.<sup id="cite_ref-pmid8463436_32-1" class="reference"><a href="#cite_note-pmid8463436-32"><span>[</span>32<span>]</span></a></sup><sup id="cite_ref-pmid18158710_39-0" class="reference"><a href="#cite_note-pmid18158710-39"><span>[</span>39<span>]</span></a></sup><sup id="cite_ref-Graham2004_40-0" class="reference"><a href="#cite_note-Graham2004-40"><span>[</span>40<span>]</span></a></sup></p>
<p>Co-administration of atorvastatin with one of <a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a> inhibitors such as <a href="/wiki/Itraconazole" title="Itraconazole">itraconazole</a>,<sup id="cite_ref-pmid11061579_41-0" class="reference"><a href="#cite_note-pmid11061579-41"><span>[</span>41<span>]</span></a></sup> <a href="/wiki/Telithromycin" title="Telithromycin">telithromycin</a>, and <a href="/wiki/Voriconazole" title="Voriconazole">voriconazole</a>, may increase serum concentrations of atorvastatin, which may lead to adverse reactions. This is less likely to happen with other CYP3A4 inhibitors such as <a href="/wiki/Diltiazem" title="Diltiazem">diltiazem</a>, <a href="/wiki/Erythromycin" title="Erythromycin">erythromycin</a>, <a href="/wiki/Fluconazole" title="Fluconazole">fluconazole</a>, <a href="/wiki/Ketoconazole" title="Ketoconazole">ketoconazole</a>, <a href="/wiki/Clarithromycin" title="Clarithromycin">clarithromycin</a>, <a href="/wiki/Cyclosporine" title="Cyclosporine" class="mw-redirect">cyclosporine</a>, <a href="/wiki/Protease_inhibitor_(pharmacology)" title="Protease inhibitor (pharmacology)">protease inhibitors</a>, or <a href="/wiki/Verapamil" title="Verapamil">verapamil</a>,<sup id="cite_ref-pmid17178259_42-0" class="reference"><a href="#cite_note-pmid17178259-42"><span>[</span>42<span>]</span></a></sup> and only rarely with other CYP3A4 inhibitors, such as <a href="/wiki/Amiodarone" title="Amiodarone">amiodarone</a> and <a href="/wiki/Aprepitant" title="Aprepitant">aprepitant</a>.<sup id="cite_ref-pmid12036392_30-1" class="reference"><a href="#cite_note-pmid12036392-30"><span>[</span>30<span>]</span></a></sup> Often, <a href="/wiki/Bosentan" title="Bosentan">bosentan</a>, <a href="/wiki/Fosphenytoin" title="Fosphenytoin">fosphenytoin</a>, and <a href="/wiki/Phenytoin" title="Phenytoin">phenytoin</a>, which are CYP3A4 inducers, can decrease the plasma concentrations of atorvastatin. Only rarely, though, <a href="/wiki/Barbiturate" title="Barbiturate">barbiturates</a>, <a href="/wiki/Carbamazepine" title="Carbamazepine">carbamazepine</a>, <a href="/wiki/Efavirenz" title="Efavirenz">efavirenz</a>, <a href="/wiki/Nevirapine" title="Nevirapine">nevirapine</a>, <a href="/wiki/Oxcarbazepine" title="Oxcarbazepine">oxcarbazepine</a>, <a href="/wiki/Rifampicin" title="Rifampicin">rifampin</a>, and <a href="/wiki/Rifamycin" title="Rifamycin">rifamycin</a>,<sup id="cite_ref-pmid16084850_43-0" class="reference"><a href="#cite_note-pmid16084850-43"><span>[</span>43<span>]</span></a></sup> which are also CYP3A4 inducers, can decrease the plasma concentrations of atorvastatin. <a href="/wiki/Oral_contraceptive" title="Oral contraceptive" class="mw-redirect">Oral contraceptives</a> increased AUC values for <a href="/wiki/Norethisterone" title="Norethisterone">norethisterone</a> and <a href="/wiki/Ethinyl_estradiol" title="Ethinyl estradiol">ethinyl estradiol</a>; these increases should be considered when selecting an oral contraceptive for a woman taking atorvastatin.<sup id="cite_ref-AutoYG-7_44-0" class="reference"><a href="#cite_note-AutoYG-7-44"><span>[</span>44<span>]</span></a></sup></p>
<p><a href="/wiki/Antacid" title="Antacid">Antacids</a> can rarely decrease the plasma concentrations of statin drugs, but do not affect the <a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">LDL-C</a>-lowering <a href="/wiki/Efficacy" title="Efficacy">efficacy</a>.<sup id="cite_ref-pmid15901588_45-0" class="reference"><a href="#cite_note-pmid15901588-45"><span>[</span>45<span>]</span></a></sup></p>
<p><a href="/wiki/Niacin" title="Niacin">Niacin</a> also is proved to increase the risk of myopathy or rhabdomyolysis.<sup id="cite_ref-pmid12036392_30-2" class="reference"><a href="#cite_note-pmid12036392-30"><span>[</span>30<span>]</span></a></sup></p>
<p>Statins may also alter the concentrations of other drugs, such as <a href="/wiki/Warfarin" title="Warfarin">warfarin</a> or <a href="/wiki/Digoxin" title="Digoxin">digoxin</a>, leading to alterations in effect or a requirement for clinical monitoring.<sup id="cite_ref-pmid12036392_30-3" class="reference"><a href="#cite_note-pmid12036392-30"><span>[</span>30<span>]</span></a></sup></p>
<p><a href="/wiki/Vitamin_D" title="Vitamin D">Vitamin D</a> supplementation lowers atorvastatin and active metabolite concentrations, yet <a href="/wiki/Synergy" title="Synergy">synergistically</a> reduces LDL and total <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a> concentrations.<sup id="cite_ref-pmid18754003_46-0" class="reference"><a href="#cite_note-pmid18754003-46"><span>[</span>46<span>]</span></a></sup> <a href="/wiki/Grapefruit_juice" title="Grapefruit juice">Grapefruit juice</a> components are known inhibitors of intestinal CYP3A4.</p>
<p>Co-administration of grapefruit juice with atorvastatin may cause an increase in <a href="/wiki/Cmax_(pharmacology)" title="Cmax (pharmacology)">C<sub>max</sub></a> and AUC, which can lead to adverse reactions or overdose toxicity.<sup id="cite_ref-Kane2000_47-0" class="reference"><a href="#cite_note-Kane2000-47"><span>[</span>47<span>]</span></a></sup></p>
<p>A few cases of myopathy have been reported when atorvastatin is given with <a href="/wiki/Colchicine" title="Colchicine">colchicine</a>.<sup id="cite_ref-url__atorvastatin_labeling.pfizer.com_17-11" class="reference"><a href="#cite_note-url_atorvastatin_labeling.pfizer.com-17"><span>[</span>17<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Mechanism_of_action">Mechanism of action</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=13" title="Edit section: Mechanism of action">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="hatnote relarticle mainarticle">Main article: <a href="/wiki/Statin" title="Statin">Statin</a></div>
<p>As with other statins, atorvastatin is a competitive <a href="/wiki/Enzyme_inhibitor" title="Enzyme inhibitor">inhibitor</a> of <a href="/wiki/HMG-CoA_reductase" title="HMG-CoA reductase">HMG-CoA reductase</a>. Unlike most others, however, it is a completely <a href="/wiki/Chemical_synthesis" title="Chemical synthesis">synthetic</a> compound. HMG-CoA reductase catalyzes the reduction of <a href="/wiki/HMG-CoA_reductase_pathway" title="HMG-CoA reductase pathway" class="mw-redirect">3-hydroxy-3-methylglutaryl-coenzyme A</a> (HMG-CoA) to <a href="/wiki/Mevalonate" title="Mevalonate" class="mw-redirect">mevalonate</a>, which is the <a href="/wiki/Rate-determining_step" title="Rate-determining step">rate-limiting step</a> in hepatic <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a> biosynthesis. Inhibition of the enzyme decreases <i><a href="/wiki/De_novo_synthesis" title="De novo synthesis">de novo</a></i> cholesterol synthesis, increasing expression of low-density lipoprotein receptors (<a href="/wiki/LDL_receptor" title="LDL receptor">LDL receptors</a>) on <a href="/wiki/Hepatocyte" title="Hepatocyte">hepatocytes</a>. This increases LDL uptake by the hepatocytes, decreasing the amount of LDL-cholesterol in the blood. Like other statins, atorvastatin also reduces blood levels of <a href="/wiki/Triglyceride" title="Triglyceride">triglycerides</a> and slightly increases levels of <a href="/wiki/High_density_lipoprotein" title="High density lipoprotein" class="mw-redirect">HDL-cholesterol</a>.</p>
<p>Recent studies have shown that in patients suffering from <a href="/wiki/Acute_coronary_syndrome" title="Acute coronary syndrome">acute coronary syndrome</a>, high-dose statin treatment may play a plaque-stabilizing role. At high doses, statins have anti-inflammatory effects, incite reduction of the necrotic plaque core, and improve endothelial function, leading to plaque stabilization and, sometimes, plaque regression. However, there is an increased risk of statin-associated adverse effects with such high-dose statin treatment.<sup id="cite_ref-Rosa_501.E2.80.9315_25-1" class="reference"><a href="#cite_note-Rosa_501.E2.80.9315-25"><span>[</span>25<span>]</span></a></sup> There is a similar thought process and risks associated with using high-dose statins to prevent recurrence of <a href="/wiki/Thrombotic_stroke" title="Thrombotic stroke" class="mw-redirect">thrombotic stroke</a>.<sup id="cite_ref-Furie_1994.E2.80.935_26-1" class="reference"><a href="#cite_note-Furie_1994.E2.80.935-26"><span>[</span>26<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pharmacodynamics">Pharmacodynamics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=14" title="Edit section: Pharmacodynamics">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The liver is the primary site of action of atorvastatin, as this is the principal site of both cholesterol synthesis and LDL clearance. It is the dosage of atorvastatin, rather than systemic drug concentration, which correlates with extent of LDL-C reduction.<sup id="cite_ref-url__atorvastatin_labeling.pfizer.com_17-12" class="reference"><a href="#cite_note-url_atorvastatin_labeling.pfizer.com-17"><span>[</span>17<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pharmacokinetics">Pharmacokinetics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=15" title="Edit section: Pharmacokinetics">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Absorption">Absorption</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=16" title="Edit section: Absorption">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Atorvastatin undergoes rapid absorption when taken orally, with an approximate time to maximum plasma concentration (<a href="/wiki/Transport_maximum" title="Transport maximum">T<sub>max</sub></a>) of 1–2 h. The absolute <a href="/wiki/Bioavailability" title="Bioavailability">bioavailability</a> of the drug is about 14%, but the systemic availability for <a href="/wiki/HMG-CoA_reductase" title="HMG-CoA reductase">HMG-CoA reductase</a> activity is approximately 30%. Atorvastatin undergoes high intestinal clearance and <a href="/wiki/First-pass_metabolism" title="First-pass metabolism" class="mw-redirect">first-pass metabolism</a>, which is the main cause for the low systemic availability. Administration of atorvastatin with food produces a 25% reduction in <a href="/wiki/Cmax_(pharmacology)" title="Cmax (pharmacology)">C<sub>max</sub></a> (rate of absorption) and a 9% reduction in <a href="/wiki/Integral" title="Integral">AUC</a> (extent of absorption), although food does not affect the plasma <a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">LDL-C</a>-lowering <a href="/wiki/Efficacy" title="Efficacy">efficacy</a> of atorvastatin. Evening dose administration is known to reduce the C<sub>max</sub> and AUC by 30% each. However, time of administration does not affect the plasma LDL-C-lowering efficacy of atorvastatin.</p>
<h3><span class="mw-headline" id="Distribution">Distribution</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=17" title="Edit section: Distribution">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The mean <a href="/wiki/Volume_of_distribution" title="Volume of distribution">volume of distribution</a> of atorvastatin is approximately 381 L. It is highly protein bound (≥98%), and studies have shown it is likely secreted into human breastmilk.</p>
<h3><span class="mw-headline" id="Metabolism">Metabolism</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=18" title="Edit section: Metabolism">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Atorvastatin <a href="/wiki/Metabolism" title="Metabolism">metabolism</a> is primarily through <a href="/wiki/Cytochrome_P450" title="Cytochrome P450">cytochrome P450</a> <a href="/wiki/CYP3A4" title="CYP3A4">3A4</a> <a href="/wiki/Hydroxylation" title="Hydroxylation">hydroxylation</a> to form active ortho- and parahydroxylated <a href="/wiki/Metabolites" title="Metabolites" class="mw-redirect">metabolites</a>, as well as various <a href="/wiki/Beta-oxidation" title="Beta-oxidation" class="mw-redirect">beta-oxidation</a> metabolites. The ortho- and parahydroxylated metabolites are responsible for 70% of systemic <a href="/wiki/HMG-CoA_reductase" title="HMG-CoA reductase">HMG-CoA reductase</a> activity. The ortho-hydroxy metabolite undergoes further metabolism via <a href="/wiki/Glucuronidation" title="Glucuronidation">glucuronidation</a>. As a substrate for the CYP3A4 isozyme, it has shown susceptibility to inhibitors and inducers of CYP3A4 to produce increased or decreased plasma concentrations, respectively. This interaction was tested <i>in vitro</i> with concurrent administration of <a href="/wiki/Erythromycin" title="Erythromycin">erythromycin</a>, a known CYP3A4 isozyme inhibitor, which resulted in increased plasma concentrations of atorvastatin. It is also an inhibitor of cytochrome 3A4.</p>
<h3><span class="mw-headline" id="Excretion">Excretion</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=19" title="Edit section: Excretion">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Atorvastatin is primarily eliminated via <a href="/wiki/Hepatic" title="Hepatic" class="mw-redirect">hepatic</a> <a href="/wiki/Biliary" title="Biliary" class="mw-redirect">biliary</a> excretion, with less than 2% recovered in the <a href="/wiki/Urine" title="Urine">urine</a>. <a href="/wiki/Bile" title="Bile">Bile</a> elimination follows hepatic and/or extrahepatic metabolism. There does not appear to be any <a href="/wiki/Enterohepatic_circulation" title="Enterohepatic circulation">entero-hepatic recirculation</a>. Atorvastatin has an approximate elimination <a href="/wiki/Half-life" title="Half-life">half-life</a> of 14 h. Noteworthy, the HMG-CoA reductase inhibitory activity appears to have a half-life of 20–30 h, which is thought to be due to the active metabolites. Atorvastatin is also a substrate of the intestinal <a href="/wiki/P-glycoprotein" title="P-glycoprotein">P-glycoprotein</a> efflux transporter, which pumps the drug back into the intestinal lumen during drug absorption.<sup id="cite_ref-pmid12036392_30-4" class="reference"><a href="#cite_note-pmid12036392-30"><span>[</span>30<span>]</span></a></sup></p>
<p>In <a href="/wiki/Liver_failure" title="Liver failure">hepatic insufficiency</a>, plasma drug concentrations are significantly affected by concurrent liver disease. Patients with A-stage liver disease show a four-fold increase in both C<sub>max</sub> and AUC. Patients with B-stage liver disease show a 16-fold increase in C<sub>max</sub> and an 11-fold increase in AUC.</p>
<p><a href="/wiki/Geriatrics" title="Geriatrics">Geriatric</a> patients (&gt;65 years old) exhibit altered pharmacokinetics of atorvastatin compared to young adults, with mean AUC and C<sub>max</sub> values that are 40% and 30% higher, respectively. Additionally, healthy elderly patients show a greater pharmacodynamic response to atorvastatin at any dose; therefore, this population may have lower effective doses.<sup id="cite_ref-uspi_lipitor.pdf_31-4" class="reference"><a href="#cite_note-uspi_lipitor.pdf-31"><span>[</span>31<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pharmacogenetics">Pharmacogenetics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=20" title="Edit section: Pharmacogenetics">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Several genetic <a href="/wiki/Genetic_polymorphism" title="Genetic polymorphism" class="mw-redirect">polymorphisms</a> have been found to be associated with a higher incidence of undesirable side effects of atorvastatin. This phenomenon is suspected to be related to increased plasma levels of pharmacologically active metabolites, such as atorvastatin lactone and p-hydroxyatorvastatin. Atorvastatin and its active metabolites may be monitored in potentially susceptible patients using specific chromatographic techniques.<sup id="cite_ref-pmid22368281_48-0" class="reference"><a href="#cite_note-pmid22368281-48"><span>[</span>48<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Chemical_synthesis">Chemical synthesis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=21" title="Edit section: Chemical synthesis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:602px;"><a href="/wiki/File:Atorvastatin_synthesis_stereocenter_commercial.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/99/Atorvastatin_synthesis_stereocenter_commercial.png/600px-Atorvastatin_synthesis_stereocenter_commercial.png" width="600" height="127" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/99/Atorvastatin_synthesis_stereocenter_commercial.png/900px-Atorvastatin_synthesis_stereocenter_commercial.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/99/Atorvastatin_synthesis_stereocenter_commercial.png/1200px-Atorvastatin_synthesis_stereocenter_commercial.png 2x" data-file-width="2095" data-file-height="442" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Atorvastatin_synthesis_stereocenter_commercial.png" class="internal" title="Enlarge"></a></div>
Atorvastatin synthesis in commercial production (process) chemistry. The key step of establishing this drug's stereocenters, through initial use of an inexpensive natural product (<a href="/wiki/Chiral_pool" title="Chiral pool" class="mw-redirect">chiral pool</a> approach).</div>
</div>
</div>
<div class="thumb tright">
<div class="thumbinner" style="width:602px;"><a href="/wiki/File:Atorvastatin_synthesis_stereocenter_firstdiscovery.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/13/Atorvastatin_synthesis_stereocenter_firstdiscovery.png/600px-Atorvastatin_synthesis_stereocenter_firstdiscovery.png" width="600" height="172" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/13/Atorvastatin_synthesis_stereocenter_firstdiscovery.png/900px-Atorvastatin_synthesis_stereocenter_firstdiscovery.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/13/Atorvastatin_synthesis_stereocenter_firstdiscovery.png/1200px-Atorvastatin_synthesis_stereocenter_firstdiscovery.png 2x" data-file-width="2365" data-file-height="679" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Atorvastatin_synthesis_stereocenter_firstdiscovery.png" class="internal" title="Enlarge"></a></div>
Atorvastatin synthesis during discovery chemistry. The key step of establishing stereocenters, using of a chiral ester auxiliary approach.</div>
</div>
</div>
<p>The first synthesis of atorvastatin at Parke-Davis that occurred during <a href="/wiki/Drug_discovery" title="Drug discovery">drug discovery</a> was <a href="/wiki/Racemic_mixture#synthesis" title="Racemic mixture">racemic</a> followed by <a href="/wiki/Chiral_column_chromatography" title="Chiral column chromatography">chiral chromatographic</a> separation of the <a href="/wiki/Enantiomer" title="Enantiomer">enantiomers</a>. An early <a href="/wiki/Enantioselective_synthesis" title="Enantioselective synthesis">enantioselective</a> route to atorvastatin made use of an ester <a href="/wiki/Chiral_auxiliary" title="Chiral auxiliary">chiral auxiliary</a> to set the stereochemistry of the first of the two alcohol functional groups via a diastereoselective <a href="/wiki/Aldol_reaction" title="Aldol reaction">aldol reaction</a>.<sup id="cite_ref-Roth_2002_3-2" class="reference"><a href="#cite_note-Roth_2002-3"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-49" class="reference"><a href="#cite_note-49"><span>[</span>49<span>]</span></a></sup> Once the compound entered <a href="/wiki/Pre-clinical_development" title="Pre-clinical development">pre-clinical development</a>, <a href="/wiki/Process_chemistry" title="Process chemistry">process chemistry</a> developed a cost-effective and scalable synthesis.<sup id="cite_ref-Roth_2002_3-3" class="reference"><a href="#cite_note-Roth_2002-3"><span>[</span>3<span>]</span></a></sup> In atorvastatin's case, a key element of the overall synthesis was ensuring stereochemical purity in the final drug substance, and hence establishing the first stereocenter became a key aspect of the overall design. The final commercial production of atorvastatin relied on a <a href="/wiki/Chiral_pool" title="Chiral pool" class="mw-redirect">chiral pool</a> approach, where the stereochemistry of the first alcohol functional group was carried into the synthesis—through the choice of <a href="/wiki/Erythorbic_acid" title="Erythorbic acid">isoascorbic acid</a>, an inexpensive and easily sourced plant-derived natural product.<sup id="cite_ref-Roth_2002_3-4" class="reference"><a href="#cite_note-Roth_2002-3"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-50" class="reference"><a href="#cite_note-50"><span>[</span>50<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=22" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Bruce Roth, who was hired by Warner-Lambert as a young chemist in 1982, had created an "experimental compound" codenamed CI 981 – later called atorvastatin – and moved it "from synthesis in 1985 into expensive clinical trials" when company executives began to balk at the cost.<sup id="cite_ref-Fortune_2003_4-2" class="reference"><a href="#cite_note-Fortune_2003-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-FT_nov_2009_51-0" class="reference"><a href="#cite_note-FT_nov_2009-51"><span>[</span>51<span>]</span></a></sup> Roth's boss Roger Newton and Ronald Cresswell supported the young chemist's costly research but Warner-Lambert was concerned that atorvastatin was a me-too version of rival <a href="/wiki/Merck_%26_Co." title="Merck &amp; Co.">Merck &amp; Co.</a>'s <a href="/wiki/Orphan_drug" title="Orphan drug">orphan drug</a> lovastatin (brand name <a href="/wiki/Mevacor" title="Mevacor" class="mw-redirect">Mevacor</a>). Mevacor, which was first marketed in 1987, was the industry's first statin and Merck's synthetic version – Zocor – was in the advanced stages of development.<sup id="cite_ref-FT_nov_2009_51-1" class="reference"><a href="#cite_note-FT_nov_2009-51"><span>[</span>51<span>]</span></a></sup></p>
<p>In 1994 the findings of a Merck-funded study were published in <i><a href="/wiki/The_Lancet" title="The Lancet">The Lancet</a></i> concluding the efficacy of statins in lowering cholesterol in 4444 Scandinavian patients proving for the first time not only that a "statin reduced “bad” LDL cholesterol but also that it led to a sharp drop in fatal heart attacks among patients with heart disease."<sup id="cite_ref-FT_nov_2009_51-2" class="reference"><a href="#cite_note-FT_nov_2009-51"><span>[</span>51<span>]</span></a></sup><sup id="cite_ref-Lancet_1994_scandinavia_52-0" class="reference"><a href="#cite_note-Lancet_1994_scandinavia-52"><span>[</span>52<span>]</span></a></sup> In 1996 Warner-Lambert entered into a co-marketing agreement with Pfizer to sell Lipitor and in 2000 Pfizer acquired Warner-Lambert 2000 for $90.2 billion.<sup id="cite_ref-WSJ_blockbuster_2000_2-1" class="reference"><a href="#cite_note-WSJ_blockbuster_2000-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Roth_2002_3-5" class="reference"><a href="#cite_note-Roth_2002-3"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-US4681893_5-1" class="reference"><a href="#cite_note-US4681893-5"><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-History_Parke-Davis_6-1" class="reference"><a href="#cite_note-History_Parke-Davis-6"><span>[</span>6<span>]</span></a></sup> Lipitor was on the market by 1996.<sup id="cite_ref-NYT_2000_7-1" class="reference"><a href="#cite_note-NYT_2000-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-FDA_Lipitor_53-0" class="reference"><a href="#cite_note-FDA_Lipitor-53"><span>[</span>53<span>]</span></a></sup> By 2003 Lipitor had become the best selling pharmaceutical in the United States.<sup id="cite_ref-Fortune_2003_4-3" class="reference"><a href="#cite_note-Fortune_2003-4"><span>[</span>4<span>]</span></a></sup> From 1996 to 2012 under the trade name Lipitor, atorvastatin became the world's best-selling drug of all time, with more than $125 billion in sales over approximately 14.5 years.<sup id="cite_ref-Crain_2011_8-1" class="reference"><a href="#cite_note-Crain_2011-8"><span>[</span>8<span>]</span></a></sup> Lipitor alone "provided up to a quarter of Pfizer Inc.'s annual revenue for years."<sup id="cite_ref-Crain_2011_8-2" class="reference"><a href="#cite_note-Crain_2011-8"><span>[</span>8<span>]</span></a></sup></p>
<p>Pfizer's patent on atorvastatin expired in November 2011.<sup id="cite_ref-CNN_Wire_Staff_54-0" class="reference"><a href="#cite_note-CNN_Wire_Staff-54"><span>[</span>54<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Formulations">Formulations</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=23" title="Edit section: Formulations">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Atorvastatin40mg.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/da/Atorvastatin40mg.jpg/220px-Atorvastatin40mg.jpg" width="220" height="165" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/da/Atorvastatin40mg.jpg/330px-Atorvastatin40mg.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/da/Atorvastatin40mg.jpg/440px-Atorvastatin40mg.jpg 2x" data-file-width="640" data-file-height="480" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Atorvastatin40mg.jpg" class="internal" title="Enlarge"></a></div>
Pack and tablet of atorvastatin (Lipitor) 40mg</div>
</div>
</div>
<p>Atorvastatin calcium tablets are marketed by <a href="/wiki/Pfizer" title="Pfizer">Pfizer</a> under the trade name Lipitor<sup id="cite_ref-MPR_55-0" class="reference"><a href="#cite_note-MPR-55"><span>[</span>55<span>]</span></a></sup> for oral administration. Tablets are white, elliptical, and film-coated. Pfizer also packages the drug in combination with other drugs, such as with <a href="/wiki/Atorvastatin/amlodipine" title="Atorvastatin/amlodipine">Caduet</a>.<sup id="cite_ref-NewsMed_56-0" class="reference"><a href="#cite_note-NewsMed-56"><span>[</span>56<span>]</span></a></sup> Pfizer recommends that patients do not break tablets in half to take half-doses, even when this is recommended by their doctors.</p>
<h2><span class="mw-headline" id="Generic_availability">Generic availability</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=24" title="Edit section: Generic availability">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Pfizer's U.S. patent on Lipitor expired on 30 November 2011.<sup id="cite_ref-CNN_Wire_Staff_54-1" class="reference"><a href="#cite_note-CNN_Wire_Staff-54"><span>[</span>54<span>]</span></a></sup> Initially, generic atorvastatin was manufactured only by <a href="/wiki/Actavis" title="Actavis">Watson Pharmaceuticals</a> and India's <a href="/wiki/Ranbaxy_Laboratories" title="Ranbaxy Laboratories">Ranbaxy Laboratories</a>. Prices for the generic version did not drop to the level of other generics—$10 or less for a month's supply—until other manufacturers began to supply the drug in May 2012.<sup id="cite_ref-57" class="reference"><a href="#cite_note-57"><span>[</span>57<span>]</span></a></sup></p>
<p>In other countries, atorvastatin calcium is made in tablet form by generic drug makers under various brand names including Stator, Atorvastatin Teva, Litorva, Torid, Atoris, Atorlip, Mactor, Lipvas, Sortis, Torvast, Torvacard, Totalip, and Tulip.<sup id="cite_ref-Pfizer_2008_Annual_Report_58-0" class="reference"><a href="#cite_note-Pfizer_2008_Annual_Report-58"><span>[</span>58<span>]</span></a></sup> Pfizer also makes its own generic version under the name Zarator, which is the sole <a href="/wiki/Pharmac" title="Pharmac">Pharmac</a>-subsidised brand of atorvastatin in New Zealand.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59"><span>[</span>59<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Drug_recall">Drug recall</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=25" title="Edit section: Drug recall">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>On 9 November 2012, Indian drugmaker <a href="/wiki/Ranbaxy_Laboratories" title="Ranbaxy Laboratories">Ranbaxy Laboratories</a> Ltd. voluntarily recalled 10-, 20- and 40-mg doses of its generic version of atorvastatin in the United States. The lots of atorvastatin, packaged in bottles of 90 and 500 tablets, were recalled due to possible contamination with very small glass particles similar to the size of a grain of sand (less than 1&#160;mm in size). The FDA received no reports of injury from the contamination.<sup id="cite_ref-60" class="reference"><a href="#cite_note-60"><span>[</span>60<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=26" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-width" style="-moz-column-width: 35em; -webkit-column-width: 35em; column-width: 35em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-LiptHome-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-LiptHome_1-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.lipitor.com/">"Pfizer product promotion page (Lipitor)"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2011-12-05</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.btitle=Pfizer+product+promotion+page+%28Lipitor%29&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.lipitor.com%2F&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-WSJ_blockbuster_2000-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-WSJ_blockbuster_2000_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WSJ_blockbuster_2000_2-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Winslow, Ron (24 January 2000). <a rel="nofollow" class="external text" href="http://www.wsj.com/articles/SB948677773420632448">"The Birth of a Blockbuster: Lipitor's Route out of the Lab"</a>. <i><a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a></i>. Ann Arbor, Michigan<span class="reference-accessdate">. Retrieved <span class="nowrap">24 November</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=The+Birth+of+a+Blockbuster%3A+Lipitor%27s+Route+out+of+the+Lab&amp;rft.au=Winslow%2C+Ron&amp;rft.date=2000-01-24&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.wsj.com%2Farticles%2FSB948677773420632448&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Roth_2002-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-Roth_2002_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Roth_2002_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Roth_2002_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Roth_2002_3-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Roth_2002_3-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Roth_2002_3-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Roth BD (2002). "The discovery and development of atorvastatin, a potent novel hypolipidemic agent". <i>Prog Med Chem</i>. Progress in Medicinal Chemistry <b>40</b>: 1–22. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0079-6468%2808%2970080-8">10.1016/S0079-6468(08)70080-8</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-444-51054-9" title="Special:BookSources/978-0-444-51054-9">978-0-444-51054-9</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12516521">12516521</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=The+discovery+and+development+of+atorvastatin%2C+a+potent+novel+hypolipidemic+agent&amp;rft.au=Roth+BD&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0079-6468%2808%2970080-8&amp;rft_id=info%3Apmid%2F12516521&amp;rft.isbn=978-0-444-51054-9&amp;rft.jtitle=Prog+Med+Chem&amp;rft.pages=1-22&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=40" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Fortune_2003-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-Fortune_2003_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Fortune_2003_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Fortune_2003_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Fortune_2003_4-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Simons, John (20 January 2003). <a rel="nofollow" class="external text" href="http://archive.fortune.com/magazines/fortune/fortune_archive/2003/01/20/335643/index.htm">"The $10 Billion Pill Hold the fries, please. Lipitor, the cholesterol-lowering drug, has become the bestselling pharmaceutical in history. Here's how Pfizer did it"</a>. Fortune Magazine.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.aufirst=John&amp;rft.aulast=Simons&amp;rft.btitle=The+%2410+Billion+Pill+Hold+the+fries%2C+please.+Lipitor%2C+the+cholesterol-lowering+drug%2C+has+become+the+bestselling+pharmaceutical+in+history.+Here%27s+how+Pfizer+did+it&amp;rft.date=2003-01-20&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Farchive.fortune.com%2Fmagazines%2Ffortune%2Ffortune_archive%2F2003%2F01%2F20%2F335643%2Findex.htm&amp;rft.pub=Fortune+Magazine&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-US4681893-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-US4681893_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-US4681893_5-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation patent" id="CITEREFRoth_Bruce_D.1987"><a rel="nofollow" class="external text" href="http://worldwide.espacenet.com/textdoc?DB=EPODOC&amp;IDX=US4681893">US patent 4681893</a>, Roth Bruce D., "Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis", issued 1987-07-21</span><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&amp;rft.number=4681893&amp;rft.cc=US&amp;rft.title=Trans-6-%5B2-%283-+or+4-carboxamido-substituted+pyrrol-1-yl%29alkyl%5D-4-hydroxypyran-2-one+inhibitors+of+cholesterol+synthesis&amp;rft.inventor=Roth+Bruce+D.&amp;rft.date=1987-07-21&amp;rft.appldate=1986-05-30"><span style="display: none;">&#160;</span></span></span></li>
<li id="cite_note-History_Parke-Davis-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-History_Parke-Davis_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-History_Parke-Davis_6-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Milton L. Hoefle (2000). <a rel="nofollow" class="external text" href="http://www.scs.illinois.edu/~mainzv/HIST/bulletin_open_access/v25-1/v25-1%20p28-34.pdf">"The Early History of Parke-Davis and Company"</a> <span style="font-size:85%;">(PDF)</span>. <i>Bull. Hist. Chem.</i> <b>25</b> (1): 28–34.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=The+Early+History+of+Parke-Davis+and+Company&amp;rft.au=Milton+L.+Hoefle&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.scs.illinois.edu%2F~mainzv%2FHIST%2Fbulletin_open_access%2Fv25-1%2Fv25-1%2520p28-34.pdf&amp;rft.issue=1&amp;rft.jtitle=Bull.+Hist.+Chem.&amp;rft.pages=28-34&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=25" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-NYT_2000-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-NYT_2000_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NYT_2000_7-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.nytimes.com/2000/02/08/business/pfizer-gets-its-deal-to-buy-warner-lambert-for-90.2-billion.html">"Pfizer Gets Its Deal to Buy Warner-Lambert for $90.2 Billion"</a>. New York Times. 2000.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.btitle=Pfizer+Gets+Its+Deal+to+Buy+Warner-Lambert+for+%2490.2+Billion&amp;rft.date=2000&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2000%2F02%2F08%2Fbusiness%2Fpfizer-gets-its-deal-to-buy-warner-lambert-for-90.2-billion.html&amp;rft.pub=New+York+Times&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Crain_2011-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-Crain_2011_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Crain_2011_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Crain_2011_8-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.crainsnewyork.com/article/20111228/HEALTH_CARE/111229902">"Lipitor becomes world's top-selling drug"</a>. Crain's New York Business via Associated Press. 28 December 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">24 November</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.btitle=Lipitor+becomes+world%27s+top-selling+drug&amp;rft.date=2011-12-28&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.crainsnewyork.com%2Farticle%2F20111228%2FHEALTH_CARE%2F111229902&amp;rft.pub=Crain%27s+New+York+Business+via+Associated+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-AHFS-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-AHFS_9-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.drugs.com/monograph/atorvastatin-calcium.html">"Atorvastatin Calcium"</a>. Drugs.com<span class="reference-accessdate">. Retrieved <span class="nowrap">3 April</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.btitle=Atorvastatin+Calcium&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.drugs.com%2Fmonograph%2Fatorvastatin-calcium.html&amp;rft.pub=Drugs.com&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12915827-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid12915827_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid12915827_10-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid12915827_10-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">McCrindle BW, Ose L, Marais AD (July 2003). "Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial". <i>J. Pediatr.</i> <b>143</b> (1): 74–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0022-3476%2803%2900186-0">10.1016/S0022-3476(03)00186-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12915827">12915827</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Efficacy+and+safety+of+atorvastatin+in+children+and+adolescents+with+familial+hypercholesterolemia+or+severe+hyperlipidemia%3A+a+multicenter%2C+randomized%2C+placebo-controlled+trial&amp;rft.au=McCrindle+BW%2C+Ose+L%2C+Marais+AD&amp;rft.date=2003-07&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0022-3476%2803%2900186-0&amp;rft_id=info%3Apmid%2F12915827&amp;rft.issue=1&amp;rft.jtitle=J.+Pediatr.&amp;rft.pages=74-80&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=143" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nissen_2006-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-Nissen_2006_11-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM (April 2006). "Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial". <i><a href="/wiki/Journal_of_the_American_Medical_Association" title="Journal of the American Medical Association" class="mw-redirect">Journal of the American Medical Association</a></i> <b>295</b> (13): 1556–65. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Fjama.295.13.jpc60002">10.1001/jama.295.13.jpc60002</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16533939">16533939</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Effect+of+very+high-intensity+statin+therapy+on+regression+of+coronary+atherosclerosis%3A+the+ASTEROID+trial&amp;rft.au=Nissen+SE%2C+Nicholls+SJ%2C+Sipahi+I%2C+Libby+P%2C+Raichlen+JS%2C+Ballantyne+CM%2C+Davignon+J%2C+Erbel+R%2C+Fruchart+JC%2C+Tardif+JC%2C+Schoenhagen+P%2C+Crowe+T%2C+Cain+V%2C+Wolski+K%2C+Goormastic+M%2C+Tuzcu+EM&amp;rft.date=2006-04&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.295.13.jpc60002&amp;rft_id=info%3Apmid%2F16533939&amp;rft.issue=13&amp;rft.jtitle=Journal+of+the+American+Medical+Association&amp;rft.pages=1556-65&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=295" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid7749881-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid7749881_12-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Nawrocki JW, Weiss SR, Davidson MH, Sprecher DL, Schwartz SL, Lupien PJ, Jones PH, Haber HE, Black DM (May 1995). <a rel="nofollow" class="external text" href="http://atvb.ahajournals.org/cgi/content/full/15/5/678">"Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor"</a>. <i>Arterioscler. Thromb. Vasc. Biol.</i> <b>15</b> (5): 678–82. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1161%2F01.ATV.15.5.678">10.1161/01.ATV.15.5.678</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7749881">7749881</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Reduction+of+LDL+cholesterol+by+25%25+to+60%25+in+patients+with+primary+hypercholesterolemia+by+atorvastatin%2C+a+new+HMG-CoA+reductase+inhibitor&amp;rft.au=Nawrocki+JW%2C+Weiss+SR%2C+Davidson+MH%2C+Sprecher+DL%2C+Schwartz+SL%2C+Lupien+PJ%2C+Jones+PH%2C+Haber+HE%2C+Black+DM&amp;rft.date=1995-05&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fatvb.ahajournals.org%2Fcgi%2Fcontent%2Ffull%2F15%2F5%2F678&amp;rft_id=info%3Adoi%2F10.1161%2F01.ATV.15.5.678&amp;rft_id=info%3Apmid%2F7749881&amp;rft.issue=5&amp;rft.jtitle=Arterioscler.+Thromb.+Vasc.+Biol.&amp;rft.pages=678-82&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid8531308-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8531308_13-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Bakker-Arkema RG, Davidson MH, Goldstein RJ, Davignon J, Isaacsohn JL, Weiss SR, Keilson LM, Brown WV, Miller VT, Shurzinske LJ, Black DM (January 1996). "Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia". <i><a href="/wiki/Journal_of_the_American_Medical_Association" title="Journal of the American Medical Association" class="mw-redirect">Journal of the American Medical Association</a></i> <b>275</b> (2): 128–33. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Fjama.1996.03530260042029">10.1001/jama.1996.03530260042029</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8531308">8531308</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Efficacy+and+safety+of+a+new+HMG-CoA+reductase+inhibitor%2C+atorvastatin%2C+in+patients+with+hypertriglyceridemia&amp;rft.au=Bakker-Arkema+RG%2C+Davidson+MH%2C+Goldstein+RJ%2C+Davignon+J%2C+Isaacsohn+JL%2C+Weiss+SR%2C+Keilson+LM%2C+Brown+WV%2C+Miller+VT%2C+Shurzinske+LJ%2C+Black+DM&amp;rft.date=1996-01&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.1996.03530260042029&amp;rft_id=info%3Apmid%2F8531308&amp;rft.issue=2&amp;rft.jtitle=Journal+of+the+American+Medical+Association&amp;rft.pages=128-33&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=275" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16908955-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16908955_14-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Ozaki K, Kubo T, Imaki R, Shinagawa H, Fukaya H, Ohtaki K, Ozaki S, Izumi T, Aizawa Y (August 2006). <a rel="nofollow" class="external text" href="http://www.jstage.jst.go.jp/article/jat/13/4/216/_pdf">"The anti-atherosclerotic effects of lipid lowering with atorvastatin in patients with hypercholesterolemia"</a>. <i>J. Atheroscler. Thromb.</i> <b>13</b> (4): 216–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.5551%2Fjat.13.216">10.5551/jat.13.216</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16908955">16908955</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=The+anti-atherosclerotic+effects+of+lipid+lowering+with+atorvastatin+in+patients+with+hypercholesterolemia&amp;rft.au=Ozaki+K%2C+Kubo+T%2C+Imaki+R%2C+Shinagawa+H%2C+Fukaya+H%2C+Ohtaki+K%2C+Ozaki+S%2C+Izumi+T%2C+Aizawa+Y&amp;rft.date=2006-08&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.jstage.jst.go.jp%2Farticle%2Fjat%2F13%2F4%2F216%2F_pdf&amp;rft_id=info%3Adoi%2F10.5551%2Fjat.13.216&amp;rft_id=info%3Apmid%2F16908955&amp;rft.issue=4&amp;rft.jtitle=J.+Atheroscler.+Thromb.&amp;rft.pages=216-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=13" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9301631-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9301631_15-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Marais AD, Firth JC, Bateman ME, Byrnes P, Martens C, Mountney J (August 1997). "Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia". <i>Arterioscler. Thromb. Vasc. Biol.</i> <b>17</b> (8): 1527–31. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1161%2F01.ATV.17.8.1527">10.1161/01.ATV.17.8.1527</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9301631">9301631</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Atorvastatin%3A+an+effective+lipid-modifying+agent+in+familial+hypercholesterolemia&amp;rft.au=Marais+AD%2C+Firth+JC%2C+Bateman+ME%2C+Byrnes+P%2C+Martens+C%2C+Mountney+J&amp;rft.date=1997-08&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1161%2F01.ATV.17.8.1527&amp;rft_id=info%3Apmid%2F9301631&amp;rft.issue=8&amp;rft.jtitle=Arterioscler.+Thromb.+Vasc.+Biol.&amp;rft.pages=1527-31&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-AMH_2006-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-AMH_2006_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AMH_2006_16-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation book">Rossi S, ed. (2006). <i>Australian medicines handbook 2006</i>. Adelaide, S. Aust: Australian Medicines Handbook Pty Ltd. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-9757919-2-3" title="Special:BookSources/0-9757919-2-3">0-9757919-2-3</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.btitle=Australian+medicines+handbook+2006&amp;rft.date=2006&amp;rft.genre=book&amp;rft.isbn=0-9757919-2-3&amp;rft.place=Adelaide%2C+S.+Aust&amp;rft.pub=Australian+Medicines+Handbook+Pty+Ltd&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-url__atorvastatin_labeling.pfizer.com-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-url_atorvastatin_labeling.pfizer.com_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-url_atorvastatin_labeling.pfizer.com_17-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-url_atorvastatin_labeling.pfizer.com_17-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-url_atorvastatin_labeling.pfizer.com_17-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-url_atorvastatin_labeling.pfizer.com_17-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-url_atorvastatin_labeling.pfizer.com_17-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-url_atorvastatin_labeling.pfizer.com_17-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-url_atorvastatin_labeling.pfizer.com_17-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-url_atorvastatin_labeling.pfizer.com_17-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-url_atorvastatin_labeling.pfizer.com_17-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-url_atorvastatin_labeling.pfizer.com_17-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-url_atorvastatin_labeling.pfizer.com_17-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-url_atorvastatin_labeling.pfizer.com_17-12"><sup><i><b>m</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://labeling.pfizer.com/ShowLabeling.aspx?id=587">"LIPITOR (atorvastatin calcium) Tablets for oral administration"</a> <span style="font-size:85%;">(PDF)</span>. <i>Full Prescribing Information</i>. Pfizer Inc<span class="reference-accessdate">. Retrieved <span class="nowrap">18 April</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=LIPITOR+%28atorvastatin+calcium%29+Tablets+for+oral+administration&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Flabeling.pfizer.com%2FShowLabeling.aspx%3Fid%3D587&amp;rft.jtitle=Full+Prescribing+Information&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12686036-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12686036_18-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J (April 2003). "Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial". <i>Lancet</i> <b>361</b> (9364): 1149–58. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2803%2912948-0">10.1016/S0140-6736(03)12948-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12686036">12686036</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Prevention+of+coronary+and+stroke+events+with+atorvastatin+in+hypertensive+patients+who+have+average+or+lower-than-average+cholesterol+concentrations%2C+in+the+Anglo-Scandinavian+Cardiac+Outcomes+Trial--Lipid+Lowering+Arm+%28ASCOT-LLA%29%3A+a+multicentre+randomised+controlled+trial&amp;rft.au=Sever+PS%2C+Dahl%C3%B6f+B%2C+Poulter+NR%2C+Wedel+H%2C+Beevers+G%2C+Caulfield+M%2C+Collins+R%2C+Kjeldsen+SE%2C+Kristinsson+A%2C+McInnes+GT%2C+Mehlsen+J%2C+Nieminen+M%2C+O%27Brien+E%2C+Ostergren+J&amp;rft.date=2003-04&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2803%2912948-0&amp;rft_id=info%3Apmid%2F12686036&amp;rft.issue=9364&amp;rft.jtitle=Lancet&amp;rft.pages=1149-58&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=361" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12829554-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12829554_19-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Law MR, Wald NJ, Rudnicka AR (June 2003). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC162260">"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis"</a>. <i>BMJ</i> <b>326</b> (7404): 1423. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fbmj.326.7404.1423">10.1136/bmj.326.7404.1423</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC162260">162260</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12829554">12829554</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Quantifying+effect+of+statins+on+low+density+lipoprotein+cholesterol%2C+ischaemic+heart+disease%2C+and+stroke%3A+systematic+review+and+meta-analysis&amp;rft.au=Law+MR%2C+Wald+NJ%2C+Rudnicka+AR&amp;rft.date=2003-06&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC162260&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC162260&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.326.7404.1423&amp;rft_id=info%3Apmid%2F12829554&amp;rft.issue=7404&amp;rft.jtitle=BMJ&amp;rft.pages=1423&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=326" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Wilson_2008-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-Wilson_2008_20-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (May 1998). <a rel="nofollow" class="external text" href="http://circ.ahajournals.org/content/97/18/1837.full.pdf">"Prediction of coronary heart disease using risk factor categories"</a> <span style="font-size:85%;">(PDF)</span>. <i><a href="/wiki/Circulation_(journal)" title="Circulation (journal)">Circulation</a></i> <b>97</b> (18): 1837–47. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1161%2F01.CIR.97.18.1837">10.1161/01.CIR.97.18.1837</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9603539">9603539</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Prediction+of+coronary+heart+disease+using+risk+factor+categories&amp;rft.au=Wilson+PW%2C+D%27Agostino+RB%2C+Levy+D%2C+Belanger+AM%2C+Silbershatz+H%2C+Kannel+WB&amp;rft.date=1998-05&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcirc.ahajournals.org%2Fcontent%2F97%2F18%2F1837.full.pdf&amp;rft_id=info%3Adoi%2F10.1161%2F01.CIR.97.18.1837&amp;rft_id=info%3Apmid%2F9603539&amp;rft.issue=18&amp;rft.jtitle=Circulation&amp;rft.pages=1837-47&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=97" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9514454-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9514454_21-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Jones P, Kafonek S, Laurora I, Hunninghake D (March 1998). "Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)". <i><a href="/wiki/American_Journal_of_Cardiology" title="American Journal of Cardiology">American Journal of Cardiology</a></i> <b>81</b> (5): 582–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0002-9149%2897%2900965-X">10.1016/S0002-9149(97)00965-X</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9514454">9514454</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Comparative+dose+efficacy+study+of+atorvastatin+versus+simvastatin%2C+pravastatin%2C+lovastatin%2C+and+fluvastatin+in+patients+with+hypercholesterolemia+%28the+CURVES+study%29&amp;rft.au=Jones+P%2C+Kafonek+S%2C+Laurora+I%2C+Hunninghake+D&amp;rft.date=1998-03&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0002-9149%2897%2900965-X&amp;rft_id=info%3Apmid%2F9514454&amp;rft.issue=5&amp;rft.jtitle=American+Journal+of+Cardiology&amp;rft.pages=582-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=81" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15325833-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15325833_22-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH (2004). "Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial". <i>Lancet</i> <b>364</b> (9435): 685–96. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2804%2916895-5">10.1016/S0140-6736(04)16895-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15325833">15325833</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Primary+prevention+of+cardiovascular+disease+with+atorvastatin+in+type+2+diabetes+in+the+Collaborative+Atorvastatin+Diabetes+Study+%28CARDS%29%3A+multicentre+randomised+placebo-controlled+trial&amp;rft.au=Colhoun+HM%2C+Betteridge+DJ%2C+Durrington+PN%2C+Hitman+GA%2C+Neil+HA%2C+Livingstone+SJ%2C+Thomason+MJ%2C+Mackness+MI%2C+Charlton-Menys+V%2C+Fuller+JH&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2804%2916895-5&amp;rft_id=info%3Apmid%2F15325833&amp;rft.issue=9435&amp;rft.jtitle=Lancet&amp;rft.pages=685-96&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=364" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17065671-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17065671_23-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Neil HA, DeMicco DA, Luo D, Betteridge DJ, Colhoun HM, Durrington PN, Livingstone SJ, Fuller JH, Hitman GA (November 2006). "Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS)". <i>Diabetes Care</i> <b>29</b> (11): 2378–84. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2337%2Fdc06-0872">10.2337/dc06-0872</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17065671">17065671</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Analysis+of+efficacy+and+safety+in+patients+aged+65-75+years+at+randomization%3A+Collaborative+Atorvastatin+Diabetes+Study+%28CARDS%29&amp;rft.au=Neil+HA%2C+DeMicco+DA%2C+Luo+D%2C+Betteridge+DJ%2C+Colhoun+HM%2C+Durrington+PN%2C+Livingstone+SJ%2C+Fuller+JH%2C+Hitman+GA&amp;rft.date=2006-11&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2337%2Fdc06-0872&amp;rft_id=info%3Apmid%2F17065671&amp;rft.issue=11&amp;rft.jtitle=Diabetes+Care&amp;rft.pages=2378-84&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=29" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11225965-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11225965_24-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Gentile S, Turco S, Guarino G, Sasso CF, Amodio M, Magliano P, Salvatore T, Corigliano G, Agrusta M, De Simone G, Gaeta I, Oliviero B, Torella R (December 2000). "Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia". <i>Diabetes Obes Metab</i> <b>2</b> (6): 355–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1046%2Fj.1463-1326.2000.00106.x">10.1046/j.1463-1326.2000.00106.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11225965">11225965</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Comparative+efficacy+study+of+atorvastatin+vs+simvastatin%2C+pravastatin%2C+lovastatin+and+placebo+in+type+2+diabetic+patients+with+hypercholesterolaemia&amp;rft.au=Gentile+S%2C+Turco+S%2C+Guarino+G%2C+Sasso+CF%2C+Amodio+M%2C+Magliano+P%2C+Salvatore+T%2C+Corigliano+G%2C+Agrusta+M%2C+De+Simone+G%2C+Gaeta+I%2C+Oliviero+B%2C+Torella+R&amp;rft.date=2000-12&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1463-1326.2000.00106.x&amp;rft_id=info%3Apmid%2F11225965&amp;rft.issue=6&amp;rft.jtitle=Diabetes+Obes+Metab&amp;rft.pages=355-62&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Rosa_501.E2.80.9315-25"><span class="mw-cite-backlink">^ <a href="#cite_ref-Rosa_501.E2.80.9315_25-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rosa_501.E2.80.9315_25-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Rosa GM, Carbone F, Parodi A, Massimelli EA, Brunelli C, Mach F, Vuilleumier N, Montecucco F (2014). "Update on the efficacy of statin treatment in acute coronary syndromes". <i>Eur. J. Clin. Invest.</i> <b>44</b> (5): 501–15. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Feci.12255">10.1111/eci.12255</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24601937">24601937</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Update+on+the+efficacy+of+statin+treatment+in+acute+coronary+syndromes&amp;rft.au=Rosa+GM%2C+Carbone+F%2C+Parodi+A%2C+Massimelli+EA%2C+Brunelli+C%2C+Mach+F%2C+Vuilleumier+N%2C+Montecucco+F&amp;rft.date=2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Feci.12255&amp;rft_id=info%3Apmid%2F24601937&amp;rft.issue=5&amp;rft.jtitle=Eur.+J.+Clin.+Invest.&amp;rft.pages=501-15&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=44" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Furie_1994.E2.80.935-26"><span class="mw-cite-backlink">^ <a href="#cite_ref-Furie_1994.E2.80.935_26-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Furie_1994.E2.80.935_26-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Furie KL (2012). "High-dose statins should only be used in atherosclerotic strokes". <i>Stroke</i> <b>43</b> (7): 1994–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1161%2FSTROKEAHA.111.633339">10.1161/STROKEAHA.111.633339</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22581818">22581818</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=High-dose+statins+should+only+be+used+in+atherosclerotic+strokes&amp;rft.au=Furie+KL&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1161%2FSTROKEAHA.111.633339&amp;rft_id=info%3Apmid%2F22581818&amp;rft.issue=7&amp;rft.jtitle=Stroke&amp;rft.pages=1994-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=43" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11368702-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11368702_27-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)". <i>JAMA</i> <b>285</b> (19): 2486–97. 2001. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Fjama.285.19.2486">10.1001/jama.285.19.2486</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11368702">11368702</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Executive+Summary+of+The+Third+Report+of+The+National+Cholesterol+Education+Program+%28NCEP%29+Expert+Panel+on+Detection%2C+Evaluation%2C+And+Treatment+of+High+Blood+Cholesterol+In+Adults+%28Adult+Treatment+Panel+III%29&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.285.19.2486&amp;rft_id=info%3Apmid%2F11368702&amp;rft.issue=19&amp;rft.jtitle=JAMA&amp;rft.pages=2486-97&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=285" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15249516-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15249516_28-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ (2004). "Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines". <i>Circulation</i> <b>110</b> (2): 227–39. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1161%2F01.CIR.0000133317.49796.0E">10.1161/01.CIR.0000133317.49796.0E</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15249516">15249516</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Implications+of+recent+clinical+trials+for+the+National+Cholesterol+Education+Program+Adult+Treatment+Panel+III+guidelines&amp;rft.au=Grundy+SM%2C+Cleeman+JI%2C+Merz+CN%2C+Brewer+HB%2C+Clark+LT%2C+Hunninghake+DB%2C+Pasternak+RC%2C+Smith+SC%2C+Stone+NJ&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1161%2F01.CIR.0000133317.49796.0E&amp;rft_id=info%3Apmid%2F15249516&amp;rft.issue=2&amp;rft.jtitle=Circulation&amp;rft.pages=227-39&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=110" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16765141-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16765141_29-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Hermann M, Bogsrud MP, Molden E, Asberg A, Mohebi BU, Ose L, Retterstøl K (June 2006). "Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy". <i>Clin. Pharmacol. Ther.</i> <b>79</b> (6): 532–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.clpt.2006.02.014">10.1016/j.clpt.2006.02.014</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16765141">16765141</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Exposure+of+atorvastatin+is+unchanged+but+lactone+and+acid+metabolites+are+increased+several-fold+in+patients+with+atorvastatin-induced+myopathy&amp;rft.au=Hermann+M%2C+Bogsrud+MP%2C+Molden+E%2C+Asberg+A%2C+Mohebi+BU%2C+Ose+L%2C+Retterst%C3%B8l+K&amp;rft.date=2006-06&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clpt.2006.02.014&amp;rft_id=info%3Apmid%2F16765141&amp;rft.issue=6&amp;rft.jtitle=Clin.+Pharmacol.+Ther.&amp;rft.pages=532-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=79" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12036392-30"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid12036392_30-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid12036392_30-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid12036392_30-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid12036392_30-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid12036392_30-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Williams D, Feely J (2002). "Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors". <i>Clin Pharmacokinet</i> <b>41</b> (5): 343–70. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2165%2F00003088-200241050-00003">10.2165/00003088-200241050-00003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12036392">12036392</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Pharmacokinetic-pharmacodynamic+drug+interactions+with+HMG-CoA+reductase+inhibitors&amp;rft.au=Williams+D%2C+Feely+J&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2165%2F00003088-200241050-00003&amp;rft_id=info%3Apmid%2F12036392&amp;rft.issue=5&amp;rft.jtitle=Clin+Pharmacokinet&amp;rft.pages=343-70&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=41" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-uspi_lipitor.pdf-31"><span class="mw-cite-backlink">^ <a href="#cite_ref-uspi_lipitor.pdf_31-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-uspi_lipitor.pdf_31-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-uspi_lipitor.pdf_31-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-uspi_lipitor.pdf_31-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-uspi_lipitor.pdf_31-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.pfizer.com/files/products/uspi_lipitor.pdf">Lipitor: Prescribing Information</a>. Pfizer. June 2009.</span></li>
<li id="cite_note-pmid8463436-32"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid8463436_32-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid8463436_32-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Ghirlanda G, Oradei A, Manto A, Lippa S, Uccioli L, Caputo S, Greco AV, Littarru GP (March 1993). "Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study". <i>J Clin Pharmacol</i> <b>33</b> (3): 226–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fj.1552-4604.1993.tb03948.x">10.1002/j.1552-4604.1993.tb03948.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8463436">8463436</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Evidence+of+plasma+CoQ10-lowering+effect+by+HMG-CoA+reductase+inhibitors%3A+a+double-blind%2C+placebo-controlled+study&amp;rft.au=Ghirlanda+G%2C+Oradei+A%2C+Manto+A%2C+Lippa+S%2C+Uccioli+L%2C+Caputo+S%2C+Greco+AV%2C+Littarru+GP&amp;rft.date=1993-03&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fj.1552-4604.1993.tb03948.x&amp;rft_id=info%3Apmid%2F8463436&amp;rft.issue=3&amp;rft.jtitle=J+Clin+Pharmacol&amp;rft.pages=226-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=33" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><cite class="citation journal">Macedo AF, Taylor FC, Casas JP, Adler A, Prieto-Merino D, Ebrahim S (2014). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3998050">"Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis"</a>. <i>BMC Med</i> <b>12</b>: 51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1186%2F1741-7015-12-51">10.1186/1741-7015-12-51</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3998050">3998050</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24655568">24655568</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Unintended+effects+of+statins+from+observational+studies+in+the+general+population%3A+systematic+review+and+meta-analysis&amp;rft.au=Adler%2C+A&amp;rft.au=Casas%2C+JP&amp;rft.au=Ebrahim%2C+S&amp;rft.aufirst=AF&amp;rft.aulast=Macedo&amp;rft.au=Prieto-Merino%2C+D&amp;rft.au=Taylor%2C+FC&amp;rft.date=2014&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3998050&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3998050&amp;rft_id=info%3Adoi%2F10.1186%2F1741-7015-12-51&amp;rft_id=info%3Apmid%2F24655568&amp;rft.jtitle=BMC+Med&amp;rft.pages=51&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-FDA_2014_statins-34"><span class="mw-cite-backlink">^ <a href="#cite_ref-FDA_2014_statins_34-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA_2014_statins_34-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREF2014" class="citation"><a rel="nofollow" class="external text" href="http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm293330.htm#3">"FDA Expands Advice on Statin Risks"</a>, <i>FDA</i>, 31 January 2014<span class="reference-accessdate">, retrieved <span class="nowrap">24 November</span> 2015</span></cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=FDA+Expands+Advice+on+Statin+Risks&amp;rft.date=2014-01-31&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FForConsumers%2FConsumerUpdates%2Fucm293330.htm%233&amp;rft.jtitle=FDA&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-webmd_2012_diabetes-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-webmd_2012_diabetes_35-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFBoyles.2C_Salynn2012" class="citation">Boyles, Salynn (9 January 2012), <a rel="nofollow" class="external text" href="http://www.webmd.com/cholesterol-management/news/20120109/statins-may-raise-diabetes-risk-in-older-women">"Statins May Raise Diabetes Risk in Older Women: Study: Middle-Aged, Older Statin Users Had More Type 2 Diabetes"</a>, <i>WebMD Health News</i><span class="reference-accessdate">, retrieved <span class="nowrap">24 November</span> 2015</span></cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Statins+May+Raise+Diabetes+Risk+in+Older+Women%3A+Study%3A+Middle-Aged%2C+Older+Statin+Users+Had+More+Type+2+Diabetes&amp;rft.au=Boyles%2C+Salynn&amp;rft.date=2012-01-09&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.webmd.com%2Fcholesterol-management%2Fnews%2F20120109%2Fstatins-may-raise-diabetes-risk-in-older-women&amp;rft.jtitle=WebMD+Health+News&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://circ.ahajournals.org/content/126/18/e282.full">http://circ.ahajournals.org/content/126/18/e282.full</a></span></li>
<li id="cite_note-Mayo_Clinic_Staff-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-Mayo_Clinic_Staff_37-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Mayo Clinic Staff. <a rel="nofollow" class="external text" href="http://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/statin-side-effects/art-20046013">"Statin Side Effects: Weigh the Risks and Benefits"</a>. The Mayo Clinic<span class="reference-accessdate">. Retrieved <span class="nowrap">19 April</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.au=Mayo+Clinic+Staff&amp;rft.btitle=Statin+Side+Effects%3A+Weigh+the+Risks+and+Benefits&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.mayoclinic.org%2Fdiseases-conditions%2Fhigh-blood-cholesterol%2Fin-depth%2Fstatin-side-effects%2Fart-20046013&amp;rft.pub=The+Mayo+Clinic&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20507274-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20507274_38-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Kostapanos MS, Liamis GL, Milionis HJ, Elisaf MS (September 2010). "Do statins beneficially or adversely affect glucose homeostasis?". <i>Curr Vasc Pharmacol</i> <b>8</b> (5): 612–31. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2174%2F157016110792006879">10.2174/157016110792006879</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20507274">20507274</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Do+statins+beneficially+or+adversely+affect+glucose+homeostasis%3F&amp;rft.au=Kostapanos+MS%2C+Liamis+GL%2C+Milionis+HJ%2C+Elisaf+MS&amp;rft.date=2010-09&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2174%2F157016110792006879&amp;rft_id=info%3Apmid%2F20507274&amp;rft.issue=5&amp;rft.jtitle=Curr+Vasc+Pharmacol&amp;rft.pages=612-31&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18158710-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18158710_39-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Steiner G (December 2007). "Atherosclerosis in type 2 diabetes: a role for fibrate therapy?". <i>Diab Vasc Dis Res</i> <b>4</b> (4): 368–74. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3132%2Fdvdr.2007.067">10.3132/dvdr.2007.067</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18158710">18158710</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Atherosclerosis+in+type+2+diabetes%3A+a+role+for+fibrate+therapy%3F&amp;rft.au=Steiner+G&amp;rft.date=2007-12&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3132%2Fdvdr.2007.067&amp;rft_id=info%3Apmid%2F18158710&amp;rft.issue=4&amp;rft.jtitle=Diab+Vasc+Dis+Res&amp;rft.pages=368-74&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Graham2004-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-Graham2004_40-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade L, Gurwitz JH, Chan KA, Goodman MJ, Platt R (December 2004). "Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs". <i><a href="/wiki/Journal_of_the_American_Medical_Association" title="Journal of the American Medical Association" class="mw-redirect">Journal of the American Medical Association</a></i> <b>292</b> (21): 2585–90. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Fjama.292.21.2585">10.1001/jama.292.21.2585</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15572716">15572716</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Incidence+of+hospitalized+rhabdomyolysis+in+patients+treated+with+lipid-lowering+drugs&amp;rft.au=Graham+DJ%2C+Staffa+JA%2C+Shatin+D%2C+Andrade+SE%2C+Schech+SD%2C+La+Grenade+L%2C+Gurwitz+JH%2C+Chan+KA%2C+Goodman+MJ%2C+Platt+R&amp;rft.date=2004-12&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.292.21.2585&amp;rft_id=info%3Apmid%2F15572716&amp;rft.issue=21&amp;rft.jtitle=Journal+of+the+American+Medical+Association&amp;rft.pages=2585-90&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=292" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11061579-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11061579_41-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Mazzu AL, Lasseter KC, Shamblen EC, Agarwal V, Lettieri J, Sundaresen P (October 2000). "Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin". <i>Clin. Pharmacol. Ther.</i> <b>68</b> (4): 391–400. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1067%2Fmcp.2000.110537">10.1067/mcp.2000.110537</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11061579">11061579</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Itraconazole+alters+the+pharmacokinetics+of+atorvastatin+to+a+greater+extent+than+either+cerivastatin+or+pravastatin&amp;rft.au=Mazzu+AL%2C+Lasseter+KC%2C+Shamblen+EC%2C+Agarwal+V%2C+Lettieri+J%2C+Sundaresen+P&amp;rft.date=2000-10&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1067%2Fmcp.2000.110537&amp;rft_id=info%3Apmid%2F11061579&amp;rft.issue=4&amp;rft.jtitle=Clin.+Pharmacol.+Ther.&amp;rft.pages=391-400&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=68" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17178259-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17178259_42-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Neuvonen PJ, Niemi M, Backman JT (December 2006). "Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance". <i>Clin. Pharmacol. Ther.</i> <b>80</b> (6): 565–81. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.clpt.2006.09.003">10.1016/j.clpt.2006.09.003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17178259">17178259</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Drug+interactions+with+lipid-lowering+drugs%3A+mechanisms+and+clinical+relevance&amp;rft.au=Neuvonen+PJ%2C+Niemi+M%2C+Backman+JT&amp;rft.date=2006-12&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clpt.2006.09.003&amp;rft_id=info%3Apmid%2F17178259&amp;rft.issue=6&amp;rft.jtitle=Clin.+Pharmacol.+Ther.&amp;rft.pages=565-81&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=80" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16084850-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16084850_43-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Backman JT, Luurila H, Neuvonen M, Neuvonen PJ (August 2005). "Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites". <i>Clin. Pharmacol. Ther.</i> <b>78</b> (2): 154–67. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.clpt.2005.04.007">10.1016/j.clpt.2005.04.007</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16084850">16084850</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Rifampin+markedly+decreases+and+gemfibrozil+increases+the+plasma+concentrations+of+atorvastatin+and+its+metabolites&amp;rft.au=Backman+JT%2C+Luurila+H%2C+Neuvonen+M%2C+Neuvonen+PJ&amp;rft.date=2005-08&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clpt.2005.04.007&amp;rft_id=info%3Apmid%2F16084850&amp;rft.issue=2&amp;rft.jtitle=Clin.+Pharmacol.+Ther.&amp;rft.pages=154-67&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=78" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-AutoYG-7-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-AutoYG-7_44-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6e131fe-e7df-4876-83f7-9156fc4e8228">"Lipitor"</a>. U.S. National Library of Medicine.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.btitle=Lipitor&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2Flookup.cfm%3Fsetid%3Dc6e131fe-e7df-4876-83f7-9156fc4e8228&amp;rft.pub=U.S.+National+Library+of+Medicine&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15901588-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15901588_45-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">McKenney JM (2005). "Efficacy and safety of rosuvastatin in treatment of dyslipidemia". <i>Am J Health Syst Pharm</i> <b>62</b> (10): 1033–47. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15901588">15901588</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Efficacy+and+safety+of+rosuvastatin+in+treatment+of+dyslipidemia&amp;rft.au=McKenney+JM&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F15901588&amp;rft.issue=10&amp;rft.jtitle=Am+J+Health+Syst+Pharm&amp;rft.pages=1033-47&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=62" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18754003-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18754003_46-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Schwartz JB (February 2009). "Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence". <i>Clin. Pharmacol. Ther.</i> <b>85</b> (2): 198–203. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fclpt.2008.165">10.1038/clpt.2008.165</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18754003">18754003</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Effects+of+vitamin+D+supplementation+in+atorvastatin-treated+patients%3A+a+new+drug+interaction+with+an+unexpected+consequence&amp;rft.au=Schwartz+JB&amp;rft.date=2009-02&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fclpt.2008.165&amp;rft_id=info%3Apmid%2F18754003&amp;rft.issue=2&amp;rft.jtitle=Clin.+Pharmacol.+Ther.&amp;rft.pages=198-203&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=85" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Kane2000-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kane2000_47-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Kane GC, Lipsky JJ (September 2000). "Drug-grapefruit juice interactions". <i><a href="/wiki/Mayo_Clinic_Proceedings" title="Mayo Clinic Proceedings">Mayo Clinic Proceedings</a></i> <b>75</b> (9): 933–42. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.4065%2F75.9.933">10.4065/75.9.933</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10994829">10994829</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Drug-grapefruit+juice+interactions&amp;rft.au=Kane+GC%2C+Lipsky+JJ&amp;rft.date=2000-09&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.4065%2F75.9.933&amp;rft_id=info%3Apmid%2F10994829&amp;rft.issue=9&amp;rft.jtitle=Mayo+Clinic+Proceedings&amp;rft.pages=933-42&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=75" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid22368281-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22368281_48-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Deshmukh HA, Colhoun HM, Johnson T, McKeigue PM, Betteridge DJ, Durrington PN, Fuller JH, Livingstone S, Charlton-Menys V, Neil A, Poulter N, Sever P, Shields DC, Stanton AV, Chatterjee A, Hyde C, Calle RA, Demicco DA, Trompet S, Postmus I, Ford I, Jukema JW, Caulfield M, Hitman GA (May 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3329377">"Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)"</a>. <i>J Lipid Res</i> <b>53</b> (5): 1000–1011. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1194%2Fjlr.P021113">10.1194/jlr.P021113</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3329377">3329377</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22368281">22368281</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Genome-wide+association+study+of+genetic+determinants+of+LDL-c+response+to+atorvastatin+therapy%3A+importance+of+Lp%28a%29&amp;rft.au=Deshmukh+HA%2C+Colhoun+HM%2C+Johnson+T%2C+McKeigue+PM%2C+Betteridge+DJ%2C+Durrington+PN%2C+Fuller+JH%2C+Livingstone+S%2C+Charlton-Menys+V%2C+Neil+A%2C+Poulter+N%2C+Sever+P%2C+Shields+DC%2C+Stanton+AV%2C+Chatterjee+A%2C+Hyde+C%2C+Calle+RA%2C+Demicco+DA%2C+Trompet+S%2C+Postmus+I%2C+Ford+I%2C+Jukema+JW%2C+Caulfield+M%2C+Hitman+GA&amp;rft.date=2012-05&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3329377&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3329377&amp;rft_id=info%3Adoi%2F10.1194%2Fjlr.P021113&amp;rft_id=info%3Apmid%2F22368281&amp;rft.issue=5&amp;rft.jtitle=J+Lipid+Res&amp;rft.pages=1000-1011&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=53" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><cite class="citation journal">Roth BD, Blankley CJ, Chucholowski AW, Ferguson E, Hoefle ML, Ortwine DF, Newton RS, Sekerke CS, Sliskovic DR, Wilson M (1991). "Inhibitors of Cholesterol Biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran 2-one Inhibitors of HMG-CoA Reductase. 2. Effects of Introducing Substituents at Positions Three and Four of the Pyrrole Nucleus". <i><a href="/wiki/J._Med._Chem." title="J. Med. Chem." class="mw-redirect">J. Med. Chem.</a></i> <b>34</b>: 357–366. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1021%2Fjm00105a056">10.1021/jm00105a056</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Inhibitors+of+Cholesterol+Biosynthesis.++3.+Tetrahydro-4-hydroxy-6-%5B2-%281H-pyrrol-1-yl%29ethyl%5D-2H-pyran+2-one+Inhibitors+of+HMG-CoA+Reductase.+2.++Effects+of+Introducing+Substituents+at+Positions+Three+and+Four+of+the+Pyrrole+Nucleus&amp;rft.au=Roth+BD%2C+Blankley+CJ%2C+Chucholowski+AW%2C+Ferguson+E%2C+Hoefle+ML%2C+Ortwine+DF%2C+Newton+RS%2C+Sekerke+CS%2C+Sliskovic+DR%2C+Wilson+M&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1021%2Fjm00105a056&amp;rft.jtitle=J.+Med.+Chem.&amp;rft.pages=357-366&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=34" class="Z3988"><span style="display:none;">&#160;</span></span>.</span></li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><cite class="citation book">Jie Jack Li, Douglas S. Johnson, Drago R. Sliskovic, Bruce D. Roth (2004). "Chapter 9. Atorvastatin Calcium (Lipitor)". <i>Contemporary Drug Synthesis</i>. John Wiley &amp; Sons, Inc. pp.&#160;113–125. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-471-21480-9" title="Special:BookSources/0-471-21480-9">0-471-21480-9</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Chapter+9.+Atorvastatin+Calcium+%28Lipitor%29&amp;rft.btitle=Contemporary+Drug+Synthesis&amp;rft.date=2004&amp;rft.genre=bookitem&amp;rft.isbn=0-471-21480-9&amp;rft.pages=113-125&amp;rft.pub=John+Wiley+%26+Sons%2C+Inc.&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span>.</span></li>
<li id="cite_note-FT_nov_2009-51"><span class="mw-cite-backlink">^ <a href="#cite_ref-FT_nov_2009_51-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FT_nov_2009_51-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FT_nov_2009_51-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Jack, Andrew (28 November 2009). <a rel="nofollow" class="external text" href="http://on.ft.com/TtoDU6">"The fall of the world’s best-selling drug"</a>. <i>Financial Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">24 November</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=The+fall+of+the+world%99s+best-selling+drug&amp;rft.au=Jack%2C+Andrew&amp;rft.date=2009-11-28&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fon.ft.com%2FTtoDU6&amp;rft.jtitle=Financial+Times&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Lancet_1994_scandinavia-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-Lancet_1994_scandinavia_52-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)" <b>344</b> (8934). Lancet. 19 November 1994: 1383–9.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Randomised+trial+of+cholesterol+lowering+in+4444+patients+with+coronary+heart+disease%3A+the+Scandinavian+Simvastatin+Survival+Study+%284S%29&amp;rft.date=1994-11-19&amp;rft.genre=article&amp;rft.issue=8934&amp;rft.pages=1383-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=344" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment"><code style="color:inherit; border:inherit; padding:inherit;">|access-date=</code> requires <code style="color:inherit; border:inherit; padding:inherit;">|url=</code> (<a href="/wiki/Help:CS1_errors#accessdate_missing_url" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-FDA_Lipitor-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-FDA_Lipitor_53-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails">"www.accessdata.fda.gov"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.btitle=www.accessdata.fda.gov&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fscripts%2Fcder%2Fdrugsatfda%2Findex.cfm%3Ffuseaction%3DSearch.DrugDetails&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-CNN_Wire_Staff-54"><span class="mw-cite-backlink">^ <a href="#cite_ref-CNN_Wire_Staff_54-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-CNN_Wire_Staff_54-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">CNN Wire Staff (30 November 2011). <a rel="nofollow" class="external text" href="http://edition.cnn.com/2011/11/30/health/lipitor-generic/index.html">"Lipitor loses patent, goes generic"</a>. <a href="/wiki/CNN" title="CNN">CNN</a><span class="reference-accessdate">. Retrieved <span class="nowrap">18 November</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Lipitor+loses+patent%2C+goes+generic&amp;rft.au=CNN+Wire+Staff&amp;rft.date=2011-11-30&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fedition.cnn.com%2F2011%2F11%2F30%2Fhealth%2Flipitor-generic%2Findex.html&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-MPR-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-MPR_55-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Medical Product Reviews. <a rel="nofollow" class="external text" href="http://www.medicalproductreviews.com/atorvastatin-calcium-lipitor.html">"Atorvastatin Calcium (Lipitor Tablets) - Uses, Dosage and Side Effects"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">3 May</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.au=Medical+Product+Reviews&amp;rft.btitle=Atorvastatin+Calcium+%28Lipitor+Tablets%29+-+Uses%2C+Dosage+and+Side+Effects&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.medicalproductreviews.com%2Fatorvastatin-calcium-lipitor.html&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-NewsMed-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-NewsMed_56-0">^</a></b></span> <span class="reference-text"><cite class="citation web">News Medical. <a rel="nofollow" class="external text" href="http://www.news-medical.net/health/Lipitor-What-is-Lipitor.aspx">"Lipitor - What is Lipitor?"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">3 May</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.au=News+Medical&amp;rft.btitle=Lipitor+-+What+is+Lipitor%3F&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.news-medical.net%2Fhealth%2FLipitor-What-is-Lipitor.aspx&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.nelm.nhs.uk/en/NeLM-Area/News/2012---May/30/June-Drug-Tariff-Reduced-prices-for-atorvastatin/">"Price to UK for 28 tablets from £3.25 (10mg) to £10.00 (80mg)"</a>. <a href="/wiki/National_Health_Service" title="National Health Service">National Health Service</a>. June 2012.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.btitle=Price+to+UK+for+28+tablets+from++%A33.25+%2810mg%29+to++%A310.00+%2880mg%29&amp;rft.date=2012-06&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FNews%2F2012---May%2F30%2FJune-Drug-Tariff-Reduced-prices-for-atorvastatin%2F&amp;rft.pub=National+Health+Service&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Pfizer_2008_Annual_Report-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-Pfizer_2008_Annual_Report_58-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://media.pfizer.com/files/annualreport/2008/annual/review2008.pdf">"Pfizer 2008 Annual Report"</a> <span style="font-size:85%;">(PDF)</span>. Pfizer. 23 April 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">7 August</span> 2009</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.btitle=Pfizer+2008+Annual+Report&amp;rft.date=2009-04-23&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fmedia.pfizer.com%2Ffiles%2Fannualreport%2F2008%2Fannual%2Freview2008.pdf&amp;rft.pub=Pfizer&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><cite class="citation news">Rapley, Lisa (31 May 2012). <a rel="nofollow" class="external text" href="http://www.pharmacytoday.co.nz/news/2012/may-2012/31/atorvastatin-sole-funding-announced.aspx">"Atorvastatin sole funding announced"</a>. PharmacyToday.co.nz<span class="reference-accessdate">. Retrieved <span class="nowrap">16 July</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Atorvastatin+sole+funding+announced&amp;rft.aufirst=Lisa&amp;rft.aulast=Rapley&amp;rft.date=2012-05-31&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.pharmacytoday.co.nz%2Fnews%2F2012%2Fmay-2012%2F31%2Fatorvastatin-sole-funding-announced.aspx&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.fda.gov/drugs/drugsafety/ucm329951.htm">"FDA Statement on Ranbaxy Atorvastatin Recall"</a>. FDA<span class="reference-accessdate">. Retrieved <span class="nowrap">19 April</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.btitle=FDA+Statement+on+Ranbaxy+Atorvastatin+Recall&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fdrugsafety%2Fucm329951.htm&amp;rft.pub=FDA&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="Further_reading">Further reading</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=27" title="Edit section: Further reading">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="refbegin columns references-column-width" style="-moz-column-width: 35em; -webkit-column-width: 35em; column-width: 35em;">
<ul>
<li><cite class="citation web"><a rel="nofollow" class="external text" href="http://labeling.pfizer.com/ShowLabeling.aspx?id=587">"Highlights of prescribing information"</a> <span style="font-size:85%;">(pdf)</span>. <i>Lipitor (atorvastatin calcium) Tablets for oral administration</i>. Pfizer. 2009-06-01<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-10-26</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Highlights+of+prescribing+information&amp;rft.date=2009-06-01&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Flabeling.pfizer.com%2FShowLabeling.aspx%3Fid%3D587&amp;rft.jtitle=Lipitor+%28atorvastatin+calcium%29+Tablets+for+oral+administration&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></li>
<li><cite class="citation journal">Maggon K (June 2005). "Best-selling human medicines 2002-2004". <i>Drug Discov. Today</i> <b>10</b> (11): 739–42. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS1359-6446%2805%2903468-9">10.1016/S1359-6446(05)03468-9</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15922927">15922927</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Best-selling+human+medicines+2002-2004&amp;rft.au=Maggon+K&amp;rft.date=2005-06&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS1359-6446%2805%2903468-9&amp;rft_id=info%3Apmid%2F15922927&amp;rft.issue=11&amp;rft.jtitle=Drug+Discov.+Today&amp;rft.pages=739-42&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></li>
<li><cite class="citation web">Simons J (2003-01-20). <a rel="nofollow" class="external text" href="http://money.cnn.com/magazines/fortune/fortune_archive/2003/01/20/335643/index.htm">"The $10 Billion Pill Hold the fries, please. Lipitor, the cholesterol-lowering drug, has become the bestselling pharmaceutical in history. Here's how Pfizer did it"</a>. <i>Fortune</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2011-10-26</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=The+%2410+Billion+Pill+Hold+the+fries%2C+please.+Lipitor%2C+the+cholesterol-lowering+drug%2C+has+become+the+bestselling+pharmaceutical+in+history.+Here%27s+how+Pfizer+did+it&amp;rft.au=Simons+J&amp;rft.date=2003-01-20&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fmoney.cnn.com%2Fmagazines%2Ffortune%2Ffortune_archive%2F2003%2F01%2F20%2F335643%2Findex.htm&amp;rft.jtitle=Fortune&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></li>
<li><cite class="citation web">Winslow R (2000-01-24). <a rel="nofollow" class="external text" href="http://www.oralchelation.net/data/Cholesterol/data11d.htm">"The Birth of a Blockbuster: Lipitor's Route out of the Lab"</a>. <i><a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">2011-10-26</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=The+Birth+of+a+Blockbuster%3A+Lipitor%27s+Route+out+of+the+Lab&amp;rft.au=Winslow+R&amp;rft.date=2000-01-24&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.oralchelation.net%2Fdata%2FCholesterol%2Fdata11d.htm&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></li>
<li><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.scienceblog.com/community/older/2003/C/2003363.html">"Ann Arbor chemist wins national award for drug discovery"</a>. <i>ScienceBlog</i>. American Chemical Society. 2003-03-01<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-10-26</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Ann+Arbor+chemist+wins+national+award+for+drug+discovery&amp;rft.date=2003-03-01&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.scienceblog.com%2Fcommunity%2Folder%2F2003%2FC%2F2003363.html&amp;rft.jtitle=ScienceBlog&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></li>
<li><cite class="citation web">Rowe A (2008-08-20). <a rel="nofollow" class="external text" href="http://blog.wired.com/wiredscience/2008/08/meet-the-guy-wh.html">"Meet the Guy Who Invented Lipitor"</a>. <i>Wired Science</i>. Wired.com<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-10-26</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.atitle=Meet+the+Guy+Who+Invented+Lipitor&amp;rft.au=Rowe+A&amp;rft.date=2008-08-20&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fblog.wired.com%2Fwiredscience%2F2008%2F08%2Fmeet-the-guy-wh.html&amp;rft.jtitle=Wired+Science&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></li>
<li><cite class="citation web">Bernstein M (2008-08-16). <a rel="nofollow" class="external text" href="http://www.medicalnewstoday.com/articles/118387.php">"Chemical Society To Honor 'Heroes Of Chemistry' During National Meeting"</a>. Medical News Today<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-10-26</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.au=Bernstein+M&amp;rft.btitle=Chemical+Society+To+Honor+%27Heroes+Of+Chemistry%27+During+National+Meeting&amp;rft.date=2008-08-16&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.medicalnewstoday.com%2Farticles%2F118387.php&amp;rft.pub=Medical+News+Today&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></li>
<li><cite class="citation web">He L (2003-09-27). <a rel="nofollow" class="external text" href="http://chemport.ipe.ac.cn/cgi-bin/chemport/getfiler.cgi?ID=wNidBpcIilyqFodh0jdbIG8so6dfsexvMYICS9WHsn4BeK66YvCg8oTB4mbqO6mN&amp;VER=E">"Bruce D. Roth, Pfizer Inc, USA"</a>. Chinese Academy of Sciences·Institute of Process Engineering<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-10-26</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAtorvastatin&amp;rft.au=He+L&amp;rft.btitle=Bruce+D.+Roth%2C+Pfizer+Inc%2C+USA&amp;rft.date=2003-09-27&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fchemport.ipe.ac.cn%2Fcgi-bin%2Fchemport%2Fgetfiler.cgi%3FID%3DwNidBpcIilyqFodh0jdbIG8so6dfsexvMYICS9WHsn4BeK66YvCg8oTB4mbqO6mN%26VER%3DE&amp;rft.pub=Chinese+Academy+of+Sciences+%B7Institute+of+Process+Engineering&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></li>
</ul>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Atorvastatin&amp;action=edit&amp;section=28" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=117">Atorvastatin bound to proteins</a> in the <a href="/wiki/Protein_Data_Bank" title="Protein Data Bank">PDB</a></li>
<li><a rel="nofollow" class="external text" href="http://www.lipitor.com/">Lipitor.com</a> – manufacturer's site</li>
<li><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/druginfo/meds/a600045.html">MedlinePlus Drug information: Atorvastatin (Systemic)</a> – information from USP DI Advice for the Patient</li>
<li><a rel="nofollow" class="external text" href="http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Atorvastatin">U.S. National Library of Medicine: Drug Information Portal - Atorvastatin</a></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Lipid_modifying_agents" title="Template:Lipid modifying agents"><abbr title="View this template" style=";;background:none transparent;border:none;">v</abbr></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Lipid_modifying_agents" title="Template talk:Lipid modifying agents"><abbr title="Discuss this template" style=";;background:none transparent;border:none;">t</abbr></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Lipid_modifying_agents&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;">e</abbr></a></li>
</ul>
</div>
<div style="font-size:114%"><a href="/wiki/Hypolipidemic_agent" title="Hypolipidemic agent">Lipid modifying agents</a> (<a href="/wiki/ATC_code_C10" title="ATC code C10">C10</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Human_gastrointestinal_tract" title="Human gastrointestinal tract">GI tract</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cholesterol_absorption_inhibitor" title="Cholesterol absorption inhibitor">Cholesterol absorption inhibitors</a>, <a href="/wiki/NPC1L1" title="NPC1L1">NPC1L1</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Ezetimibe" title="Ezetimibe">Ezetimibe</a></li>
<li><a href="/wiki/SCH-48461" title="SCH-48461">SCH-48461</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Bile_acid_sequestrant" title="Bile acid sequestrant">Bile acid sequestrants</a>/<a href="/wiki/Ion-exchange_resin" title="Ion-exchange resin">resins</a> (<a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">LDL</a>)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Cholestyramine" title="Cholestyramine">Cholestyramine</a></li>
<li><a href="/wiki/Colestipol" title="Colestipol">Colestipol</a></li>
<li><a href="/wiki/Colestilan" title="Colestilan">Colestilan</a></li>
<li><a href="/wiki/Colextran" title="Colextran">Colextran</a></li>
<li><a href="/wiki/Colesevelam" title="Colesevelam">Colesevelam</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Liver" title="Liver">Liver</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Statin" title="Statin">Statins</a> (<a href="/wiki/HMG-CoA_reductase" title="HMG-CoA reductase">HMG-CoA reductase</a>, <a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">LDL</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Simvastatin" title="Simvastatin">Simvastatin</a><sup>#</sup></li>
<li><strong class="selflink">Atorvastatin</strong></li>
<li><a href="/wiki/Fluvastatin" title="Fluvastatin">Fluvastatin</a></li>
<li><a href="/wiki/Lovastatin" title="Lovastatin">Lovastatin</a></li>
<li><a href="/wiki/Mevastatin" title="Mevastatin">Mevastatin</a></li>
<li><a href="/wiki/Pitavastatin" title="Pitavastatin">Pitavastatin</a></li>
<li><a href="/wiki/Pravastatin" title="Pravastatin">Pravastatin</a></li>
<li><a href="/wiki/Rosuvastatin" title="Rosuvastatin">Rosuvastatin</a></li>
<li><a href="/wiki/Cerivastatin" title="Cerivastatin">Cerivastatin</a><sup>‡</sup></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Niacin and derivatives (<a href="/wiki/High-density_lipoprotein" title="High-density lipoprotein">HDL</a> and <a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">LDL</a>)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Niceritrol" title="Niceritrol">Niceritrol</a></li>
<li><a href="/wiki/Niacin" title="Niacin">Niacin</a></li>
<li><a href="/wiki/Nicofuranose" title="Nicofuranose">Nicofuranose</a></li>
<li><a href="/wiki/Aluminium_nicotinate" title="Aluminium nicotinate">Aluminium nicotinate</a></li>
<li><a href="/wiki/Nicotinyl_alcohol" title="Nicotinyl alcohol">Nicotinyl alcohol</a></li>
<li><a href="/wiki/Acipimox" title="Acipimox">Acipimox</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Microsomal_triglyceride_transfer_protein" title="Microsomal triglyceride transfer protein">MTTP</a> inhibitors (<a href="/wiki/Very_low-density_lipoprotein" title="Very low-density lipoprotein">VLDL</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Dirlotapide" title="Dirlotapide">Dirlotapide</a></li>
<li><a href="/wiki/Lomitapide" title="Lomitapide">Lomitapide</a></li>
<li><a href="/wiki/Mitratapide" title="Mitratapide">Mitratapide</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Blood_vessel" title="Blood vessel">Blood vessels</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Fibrate" title="Fibrate">Fibrates</a> (<a href="/wiki/PPAR_agonist" title="PPAR agonist">PPAR</a>)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Clofibrate" title="Clofibrate">Clofibrate</a><sup>‡</sup></li>
<li><a href="/wiki/Bezafibrate" title="Bezafibrate">Bezafibrate</a></li>
<li><a href="/wiki/Aluminium_clofibrate" title="Aluminium clofibrate">Aluminium clofibrate</a></li>
<li><a href="/wiki/Gemfibrozil" title="Gemfibrozil">Gemfibrozil</a></li>
<li><a href="/wiki/Fenofibrate" title="Fenofibrate">Fenofibrate</a></li>
<li><a href="/wiki/Simfibrate" title="Simfibrate">Simfibrate</a></li>
<li><a href="/wiki/Ronifibrate" title="Ronifibrate">Ronifibrate</a></li>
<li><a href="/wiki/Ciprofibrate" title="Ciprofibrate">Ciprofibrate</a></li>
<li><a href="/wiki/Etofibrate" title="Etofibrate">Etofibrate</a></li>
<li><a href="/wiki/Clofibride" title="Clofibride">Clofibride</a></li>
<li><a href="/wiki/Clinofibrate" title="Clinofibrate">Clinofibrate</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CETP_inhibitor" title="CETP inhibitor">CETP inhibitors</a> (<a href="/wiki/High-density_lipoprotein" title="High-density lipoprotein">HDL</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Anacetrapib" title="Anacetrapib">Anacetrapib</a><sup>†</sup></li>
<li><a href="/wiki/Dalcetrapib" title="Dalcetrapib">Dalcetrapib</a><sup>§</sup></li>
<li><a href="/wiki/Evacetrapib" title="Evacetrapib">Evacetrapib</a><sup>§</sup></li>
<li><a href="/wiki/Torcetrapib" title="Torcetrapib">Torcetrapib</a><sup>§</sup></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Combinations</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Niacin/lovastatin" title="Niacin/lovastatin">Niacin/lovastatin</a></li>
<li><a href="/wiki/Niacin/simvastatin" title="Niacin/simvastatin">Niacin/simvastatin</a></li>
<li><a href="/wiki/Ezetimibe/simvastatin" title="Ezetimibe/simvastatin">Ezetimibe/simvastatin</a></li>
<li><a href="/wiki/Ezetimibe/atorvastatin" title="Ezetimibe/atorvastatin">Ezetimibe/atorvastatin</a></li>
<li><a href="/wiki/Laropiprant" title="Laropiprant">Niacin/laropiprant</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Dextrothyroxine" title="Dextrothyroxine">Dextrothyroxine</a><sup>‡</sup></li>
<li><a href="/wiki/Probucol" title="Probucol">Probucol</a></li>
<li><a href="/wiki/Tiadenol" title="Tiadenol">Tiadenol</a></li>
<li><a href="/wiki/Benfluorex" title="Benfluorex">Benfluorex</a></li>
<li><a href="/wiki/Meglutol" title="Meglutol">Meglutol</a></li>
<li><a href="/wiki/Omega-3-triglycerides" title="Omega-3-triglycerides" class="mw-redirect">Omega-3-triglycerides</a></li>
<li><a href="/wiki/Magnesium_pyridoxal_5-phosphate_glutamate" title="Magnesium pyridoxal 5-phosphate glutamate">Magnesium pyridoxal 5-phosphate glutamate</a></li>
<li><a href="/wiki/Policosanol" title="Policosanol">Policosanol</a></li>
<li><a href="/wiki/Lapaquistat" title="Lapaquistat">Lapaquistat</a><sup>§</sup></li>
<li><a href="/wiki/Mipomersen" title="Mipomersen">Mipomersen</a></li>
<li><a href="/wiki/Alipogene_tiparvovec" title="Alipogene tiparvovec">Alipogene tiparvovec</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px">
<div style="padding:0em 0.25em">
<div class="hlist">
<ul>
<li><sup>#</sup><a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">WHO-EM</a></li>
<li><sup>‡</sup><a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li>
<li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trials</a>:
<ul>
<li><sup>†</sup><a href="/wiki/Clinical_trial#Phase_III" title="Clinical trial">Phase III</a></li>
<li><sup>§</sup><a href="/wiki/Clinical_trial#Phase_II" title="Clinical trial">Never to phase III</a></li>
</ul>
</li>
</ul>
</div>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Nutrition_navs" title="Template:Nutrition navs"><abbr title="View this template" style=";;background:none transparent;border:none;">v</abbr></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Nutrition_navs" title="Template talk:Nutrition navs"><abbr title="Discuss this template" style=";;background:none transparent;border:none;">t</abbr></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Nutrition_navs&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;">e</abbr></a></li>
</ul>
</div>
<div style="font-size:114%">Index of <a href="/wiki/Nutrition" title="Nutrition">nutrition</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Vitamins" title="Template:Vitamins">Vitamins</a>
<ul>
<li><a href="/wiki/Template:Metabolism_of_vitamins,_coenzymes,_and_cofactors" title="Template:Metabolism of vitamins, coenzymes, and cofactors">metabolism</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Enzyme_cofactors" title="Template:Enzyme cofactors">Cofactors</a></li>
<li><a href="/wiki/Template:Metal_metabolism" title="Template:Metal metabolism">Metal metabolism</a></li>
<li>Fats
<ul>
<li><a href="/wiki/Template:Lipid_metabolism_enzymes" title="Template:Lipid metabolism enzymes">metabolism</a></li>
<li><a href="/wiki/Template:Fatty-acid_metabolism_intermediates" title="Template:Fatty-acid metabolism intermediates">intermediates</a></li>
<li><a href="/wiki/Template:Lipoprotein_metabolism" title="Template:Lipoprotein metabolism">lipoproteins</a></li>
</ul>
</li>
<li>Sugars
<ul>
<li><a href="/wiki/Template:Glycolysis" title="Template:Glycolysis">Glycolysis</a>
<ul>
<li><a href="/wiki/Template:Glycolysis_enzymes" title="Template:Glycolysis enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Glycogenesis_and_glycogenolysis_enzymes" title="Template:Glycogenesis and glycogenolysis enzymes">Glycogenesis and glycogenolysis</a>
<ul>
<li><a href="/wiki/Template:Glycogenesis_and_glycogenolysis_metabolic_intermediates" title="Template:Glycogenesis and glycogenolysis metabolic intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Fructose_and_galactose_metabolism_enzymes" title="Template:Fructose and galactose metabolism enzymes">Fructose and galactose</a>
<ul>
<li><a href="/wiki/Template:Fructose_and_galactose_metabolic_intermediates" title="Template:Fructose and galactose metabolic intermediates">intermediates</a></li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Metabolic_disorders_of_vitamins,_coenzymes,_and_cofactors" title="Template:Metabolic disorders of vitamins, coenzymes, and cofactors">Vitamins</a></li>
<li><a href="/wiki/Template:Inborn_errors_of_carbohydrate_metabolism" title="Template:Inborn errors of carbohydrate metabolism">Carbohydrate</a></li>
<li><a href="/wiki/Template:Lipid_metabolism_disorders" title="Template:Lipid metabolism disorders">Lipid</a>
<ul>
<li><a href="/wiki/Template:Lipid_storage_disorders" title="Template:Lipid storage disorders">storage</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Inborn_errors_of_metal_metabolism" title="Template:Inborn errors of metal metabolism">Metals</a></li>
<li><a href="/wiki/Template:Nutritional_pathology" title="Template:Nutritional pathology">Other</a></li>
<li><a href="/wiki/Template:Symptoms_concerning_nutrition,_metabolism_and_development" title="Template:Symptoms concerning nutrition, metabolism and development">Symptoms and signs</a></li>
<li><a href="/wiki/Template:Tests_relating_to_nutrition" title="Template:Tests relating to nutrition">Tests</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Antiobesity_preparations" title="Template:Antiobesity preparations">obesity</a></li>
<li><a href="/wiki/Template:Lipid_modifying_agents" title="Template:Lipid modifying agents">lipid-modifying</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Vitamins" title="Template:Vitamins">Vitamins</a></li>
<li><a href="/wiki/Template:Mineral_supplements" title="Template:Mineral supplements">Mineral supplements</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1163
Cached time: 20160129184025
Cache expiry: 2592000
Dynamic content: false
CPU time usage: 1.292 seconds
Real time usage: 1.428 seconds
Preprocessor visited node count: 7890/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 239493/2097152 bytes
Template argument size: 8751/2097152 bytes
Highest expansion depth: 20/40
Expensive parser function count: 2/500
Lua time usage: 0.589/10.000 seconds
Lua memory usage: 5.13 MB/50 MB
Number of Wikibase entities loaded: 10-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00% 1233.024      1 - -total
 49.36%  608.625      1 - Template:Reflist
 31.60%  389.583      1 - Template:Infobox_drug
 29.26%  360.833      3 - Template:Infobox
 21.98%  271.000     36 - Template:Cite_journal
 13.22%  162.995     23 - Template:Cite_web
  4.85%   59.769      5 - Template:Navbox
  3.99%   49.215      1 - Template:Statins
  2.53%   31.164      1 - Template:Infobox_drug/chemical_formula
  1.75%   21.541      1 - Template:Chem_molar_mass
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:634622-0!*!0!!en!4!* and timestamp 20160129184024 and revision id 701883901
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Atorvastatin&amp;oldid=701883901">https://en.wikipedia.org/w/index.php?title=Atorvastatin&amp;oldid=701883901</a>"					</div>
				<div id='catlinks' class='catlinks' data-mw='interface'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Anilides" title="Category:Anilides">Anilides</a></li><li><a href="/wiki/Category:Diols" title="Category:Diols">Diols</a></li><li><a href="/wiki/Category:Fluoroarenes" title="Category:Fluoroarenes">Fluoroarenes</a></li><li><a href="/wiki/Category:Pfizer_products" title="Category:Pfizer products">Pfizer products</a></li><li><a href="/wiki/Category:Pyrroles" title="Category:Pyrroles">Pyrroles</a></li><li><a href="/wiki/Category:Statins" title="Category:Statins">Statins</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Pages_using_citations_with_accessdate_and_no_URL" title="Category:Pages using citations with accessdate and no URL">Pages using citations with accessdate and no URL</a></li><li><a href="/wiki/Category:Articles_with_changed_DrugBank_identifier" title="Category:Articles with changed DrugBank identifier">Articles with changed DrugBank identifier</a></li><li><a href="/wiki/Category:Articles_with_changed_FDA_identifier" title="Category:Articles with changed FDA identifier">Articles with changed FDA identifier</a></li><li><a href="/wiki/Category:Chemical_articles_having_calculated_molecular_weight_overwritten" title="Category:Chemical articles having calculated molecular weight overwritten">Chemical articles having calculated molecular weight overwritten</a></li><li><a href="/wiki/Category:Drugboxes_which_contain_changes_to_verified_fields" title="Category:Drugboxes which contain changes to verified fields">Drugboxes which contain changes to verified fields</a></li><li><a href="/wiki/Category:Drugboxes_which_contain_changes_to_watched_fields" title="Category:Drugboxes which contain changes to watched fields">Drugboxes which contain changes to watched fields</a></li><li><a href="/wiki/Category:Use_dmy_dates_from_January_2011" title="Category:Use dmy dates from January 2011">Use dmy dates from January 2011</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-anonuserpage">Not logged in</li><li id="pt-anontalk"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n">Talk</a></li><li id="pt-anoncontribs"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y">Contributions</a></li><li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Atorvastatin&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Atorvastatin" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Atorvastatin"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Atorvastatin"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Atorvastatin" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Atorvastatin&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Atorvastatin&amp;action=history"  title="Past revisions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if it exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikipedia store">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Atorvastatin" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Atorvastatin" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Atorvastatin&amp;oldid=701883901" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Atorvastatin&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q668093" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Atorvastatin&amp;id=701883901" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Atorvastatin">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Atorvastatin&amp;returnto=Atorvastatin&amp;oldid=701883901&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Atorvastatin&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D8%A3%D8%AA%D9%88%D8%B1%D9%81%D8%A7%D8%B3%D8%AA%D8%A7%D8%AA%D9%8A%D9%86" title="أتورفاستاتين – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Atorvastatin" title="Atorvastatin – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Atorvastatina" title="Atorvastatina – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D8%A2%D8%AA%D9%88%D8%B1%D9%88%D8%A7%D8%B3%D8%AA%D8%A7%D8%AA%DB%8C%D9%86" title="آتورواستاتین – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Atorvastatine" title="Atorvastatine – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-ko"><a href="//ko.wikipedia.org/wiki/%EC%95%84%ED%86%A0%EB%B0%94%EC%8A%A4%ED%83%80%ED%8B%B4" title="아토바스타틴 – Korean" lang="ko" hreflang="ko">한국어</a></li><li class="interlanguage-link interwiki-hi"><a href="//hi.wikipedia.org/wiki/%E0%A4%8F%E0%A4%9F%E0%A5%8B%E0%A4%B0%E0%A4%B5%E0%A4%BE%E0%A4%B8%E0%A5%8D%E0%A4%9F%E0%A5%87%E0%A4%9F%E0%A4%BF%E0%A4%A8" title="एटोरवास्टेटिन – Hindi" lang="hi" hreflang="hi">हिन्दी</a></li><li class="interlanguage-link interwiki-id"><a href="//id.wikipedia.org/wiki/Atorvastatin" title="Atorvastatin – Indonesian" lang="id" hreflang="id">Bahasa Indonesia</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Atorvastatina" title="Atorvastatina – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-hu"><a href="//hu.wikipedia.org/wiki/Atorvasztatin" title="Atorvasztatin – Hungarian" lang="hu" hreflang="hu">Magyar</a></li><li class="interlanguage-link interwiki-ml"><a href="//ml.wikipedia.org/wiki/%E0%B4%85%E0%B4%B1%E0%B5%8D%E0%B4%B1%E0%B5%8B%E0%B5%BC%E0%B4%B5%E0%B4%BE%E0%B4%B8%E0%B5%8D%E0%B4%B1%E0%B5%8D%E0%B4%B1%E0%B4%BE%E0%B4%B1%E0%B5%8D%E0%B4%B1%E0%B4%BF%E0%B5%BB" title="അറ്റോർവാസ്റ്റാറ്റിൻ – Malayalam" lang="ml" hreflang="ml">മലയാളം</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Atorvastatine" title="Atorvastatine – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E3%82%A2%E3%83%88%E3%83%AB%E3%83%90%E3%82%B9%E3%82%BF%E3%83%81%E3%83%B3" title="アトルバスタチン – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-no"><a href="//no.wikipedia.org/wiki/Atorvastatin" title="Atorvastatin – Norwegian" lang="no" hreflang="no">Norsk bokmål</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Atorwastatyna" title="Atorwastatyna – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Atorvastatina" title="Atorvastatina – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%90%D1%82%D0%BE%D1%80%D0%B2%D0%B0%D1%81%D1%82%D0%B0%D1%82%D0%B8%D0%BD" title="Аторвастатин – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-sr"><a href="//sr.wikipedia.org/wiki/Atorvastatin" title="Atorvastatin – Serbian" lang="sr" hreflang="sr">Српски / srpski</a></li><li class="interlanguage-link interwiki-sh"><a href="//sh.wikipedia.org/wiki/Atorvastatin" title="Atorvastatin – Serbo-Croatian" lang="sh" hreflang="sh">Srpskohrvatski / српскохрватски</a></li><li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Atorvastatiini" title="Atorvastatiini – Finnish" lang="fi" hreflang="fi">Suomi</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Atorvastatin" title="Atorvastatin – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="interlanguage-link interwiki-th"><a href="//th.wikipedia.org/wiki/%E0%B8%AD%E0%B8%B0%E0%B9%82%E0%B8%97%E0%B8%A7%E0%B8%B2%E0%B8%AA%E0%B9%81%E0%B8%95%E0%B8%95%E0%B8%B4%E0%B8%99" title="อะโทวาสแตติน – Thai" lang="th" hreflang="th">ไทย</a></li><li class="interlanguage-link interwiki-uk"><a href="//uk.wikipedia.org/wiki/%D0%90%D1%82%D0%BE%D1%80%D0%B2%D0%B0%D1%81%D1%82%D0%B0%D1%82%D0%B8%D0%BD" title="Аторвастатин – Ukrainian" lang="uk" hreflang="uk">Українська</a></li><li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E9%98%BF%E6%89%98%E4%BC%90%E4%BB%96%E6%B1%80" title="阿托伐他汀 – Chinese" lang="zh" hreflang="zh">中文</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q668093#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 27 January 2016, at 04:04.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wmf:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Atorvastatin&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="/static/1.27.0-wmf.10/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/static/1.27.0-wmf.10/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /static/1.27.0-wmf.10/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>window.RLQ = window.RLQ || []; window.RLQ.push( function () {
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","user":"ready","user.groups":"ready"});mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","site","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.eventLogging.subscriber","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","mmv.bootstrap.autostart","ext.visualEditor.targetLoader","ext.wikimediaEvents","ext.navigationTiming","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"]);
} );</script><script>window.RLQ = window.RLQ || []; window.RLQ.push( function () {
mw.config.set({"wgBackendResponseTime":107,"wgHostname":"mw1101"}); /* @nomin */
} );</script>
	</body>
</html>
